BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 1067276 CN(CC1CCOC1)[C@]1(CC[C@]2(CN(C(=O)N2)c2cnc(nc2)C(F)(F)F)CC1)c1ccccc1 InChI=1S/C25H30F3N5O2/c1-32(15-18-7-12-35-16-18)24(19-5-3-2-4-6-19)10-8-23(9-11-24)17-33(22(34)31-23)20-13-29-21(30-14-20)25(26,27)28/h2-6,13-14,18H,7-12,15-17H2,1H3,(H,31,34)/t18?,23-,24+ MEKPLZGVNVGOOQ-OIPYLKGRSA-N 469657 N-tert-Butyl-4-[[2-(2-hydroxyphenyl)acetyl]amino]pyridine-2-carboxamide::US11364246, Example 1::US20200361871A1, Example 1 Anoctamin-1 Homo sapiens 210 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=469657 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=469657&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347745 441571754 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067277 CN(CC1CCOC1)[C@]1(CC[C@]2(CN(C(=O)N2)c2cnc(nc2)C(F)(F)F)CC1)c1ccccc1 InChI=1S/C25H30F3N5O2/c1-32(15-18-7-12-35-16-18)24(19-5-3-2-4-6-19)10-8-23(9-11-24)17-33(22(34)31-23)20-13-29-21(30-14-20)25(26,27)28/h2-6,13-14,18H,7-12,15-17H2,1H3,(H,31,34)/t18?,23-,24+ MEKPLZGVNVGOOQ-OIPYLKGRSA-N 469658 N-(1,1-Dimethylpropyl)-3[[2-(2-hydroxyphenyl)acetyl]amino]benzamide::US11364246, Example 1.1::US20200361871A1, Example 1.1 Anoctamin-1 Homo sapiens 560 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=469658 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=469658&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348010 441571755 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067278 CN(CC1CCOC1)[C@]1(CC[C@]2(CN(C(=O)N2)c2cnc(nc2)N2CCOCC2)CC1)c1ccccc1 InChI=1S/C28H38N6O3/c1-32(19-22-7-14-37-20-22)28(23-5-3-2-4-6-23)10-8-27(9-11-28)21-34(26(35)31-27)24-17-29-25(30-18-24)33-12-15-36-16-13-33/h2-6,17-18,22H,7-16,19-21H2,1H3,(H,31,35)/t22?,27-,28+ YNOHVEDAEWQUFO-VHRQIYPPSA-N 469669 US11364246, Example 1.2::US20200361871A1, Example 1.2 Anoctamin-1 Homo sapiens 540 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=469669 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=469669&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348072 441571766 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067279 Oc1ccc(Cl)cc1CC(=O)Nc1ccnc(c1)C(=O)NC12CC3CC(CC(C3)C1)C2 InChI=1S/C24H26ClN3O3/c25-18-1-2-21(29)17(8-18)9-22(30)27-19-3-4-26-20(10-19)23(31)28-24-11-14-5-15(12-24)7-16(6-14)13-24/h1-4,8,10,14-16,29H,5-7,9,11-13H2,(H,28,31)(H,26,27,30) PCRDRKJRUZHNSR-UHFFFAOYSA-N 509135 US11364246, Example 1.3::US20200361871A1, Example 1.3 Anoctamin-1 Homo sapiens 240 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509135 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509135&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347876 459279539 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067280 COCCC(C)(C)NC(=O)c1cc(NC(=O)Cc2cc(Cl)ccc2O)ccn1 InChI=1S/C20H24ClN3O4/c1-20(2,7-9-28-3)24-19(27)16-12-15(6-8-22-16)23-18(26)11-13-10-14(21)4-5-17(13)25/h4-6,8,10,12,25H,7,9,11H2,1-3H3,(H,24,27)(H,22,23,26) FKMUCDYUQPTYHW-UHFFFAOYSA-N 509159 US11364246, Example 1.4::US20200361871A1, Example 1.4 Anoctamin-1 Homo sapiens 400 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509159 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509159&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348162 459279563 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067281 CCC(C)(C)NC(=O)c1cccc(NC(=O)Cc2cc(Cl)ccc2O)c1 InChI=1S/C20H23ClN2O3/c1-4-20(2,3)23-19(26)13-6-5-7-16(11-13)22-18(25)12-14-10-15(21)8-9-17(14)24/h5-11,24H,4,12H2,1-3H3,(H,22,25)(H,23,26) CYQKWYQIRHOCIX-UHFFFAOYSA-N 509225 US11364246, Example 1.5::US20200361871A1, Example 1.5 Anoctamin-1 Homo sapiens 340 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509225 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509225&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 149987922 459279615 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067282 CC1(CCC1)NC(=O)c1cc(NC(=O)Cc2cc(Cl)ccc2O)ccn1 InChI=1S/C19H20ClN3O3/c1-19(6-2-7-19)23-18(26)15-11-14(5-8-21-15)22-17(25)10-12-9-13(20)3-4-16(12)24/h3-5,8-9,11,24H,2,6-7,10H2,1H3,(H,23,26)(H,21,22,25) PDRRLNUAFSDYDY-UHFFFAOYSA-N 509226 4-[[2-(5-Chloro-2-hydroxy-phenyl)acetyl]amino]-N-(1-methylcyclobutyl)pyridine-2-carboxamide::US11364246, Example 1.6::US20200361871A1, Example 1.6 Anoctamin-1 Homo sapiens 60.0 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509226 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509226&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348126 459279616 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067283 CC1(CCCCC1)NC(=O)c1cc(NC(=O)Cc2cc(Cl)ccc2O)ccn1 InChI=1S/C21H24ClN3O3/c1-21(8-3-2-4-9-21)25-20(28)17-13-16(7-10-23-17)24-19(27)12-14-11-15(22)5-6-18(14)26/h5-7,10-11,13,26H,2-4,8-9,12H2,1H3,(H,25,28)(H,23,24,27) XCLHGPDHEJOHOH-UHFFFAOYSA-N 509228 US11364246, Example 1.7::US20200361871A1, Example 1.7 Anoctamin-1 Homo sapiens 150 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509228 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509228&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347837 459279618 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067284 CC(C)(C)OC(=O)NCCC(C)(C)NC(=O)c1cc(NC(=O)Cc2cc(Cl)ccc2O)ccn1 InChI=1S/C24H31ClN4O5/c1-23(2,3)34-22(33)27-11-9-24(4,5)29-21(32)18-14-17(8-10-26-18)28-20(31)13-15-12-16(25)6-7-19(15)30/h6-8,10,12,14,30H,9,11,13H2,1-5H3,(H,27,33)(H,29,32)(H,26,28,31) KQUWZLJNQIGZBE-UHFFFAOYSA-N 509229 US11364246, Example 1.8::US20200361871A1, Example 1.8 Anoctamin-1 Homo sapiens 410 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509229 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509229&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139366504 459279619 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067285 COCC(C)(C)NC(=O)c1cccc(NC(=O)Cc2ccccc2O)c1 InChI=1S/C20H24N2O4/c1-20(2,13-26-3)22-19(25)15-8-6-9-16(11-15)21-18(24)12-14-7-4-5-10-17(14)23/h4-11,23H,12-13H2,1-3H3,(H,21,24)(H,22,25) TUAHCTQMGLOZNG-UHFFFAOYSA-N 509230 US11364246, Example 1.9::US20200361871A1, Example 1.9 Anoctamin-1 Homo sapiens 4200 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509230 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509230&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348141 459279620 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067286 Oc1ccc(Cl)cc1CC(=O)Nc1ccnc(c1)C(=O)NC1CCCCC1 InChI=1S/C20H22ClN3O3/c21-14-6-7-18(25)13(10-14)11-19(26)23-16-8-9-22-17(12-16)20(27)24-15-4-2-1-3-5-15/h6-10,12,15,25H,1-5,11H2,(H,24,27)(H,22,23,26) RMVXXBBZBIAZLQ-UHFFFAOYSA-N 509231 4-[[2-(5-Chloro-2-hydroxy-phenyl)acetyl]amino]-N-cyclohexyl-pyridine-2-carboxamide::US11364246, Example 1.10::US20200361871A1, Example 1.10 Anoctamin-1 Homo sapiens 80.0 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509231 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509231&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347813 459279621 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067287 CC(C)(C)NC(=O)c1cccc(NC(=O)Cc2cc(Cl)ccc2O)c1 InChI=1S/C19H21ClN2O3/c1-19(2,3)22-18(25)12-5-4-6-15(10-12)21-17(24)11-13-9-14(20)7-8-16(13)23/h4-10,23H,11H2,1-3H3,(H,21,24)(H,22,25) AVPMXKBMUHIWHC-UHFFFAOYSA-N 509232 N-tert-Butyl-3-[[2-(5-chloro-2-hydroxy-phenyl)acetyl]amino]benzamide::US11364246, Example 2::US20200361871A1, Example 2 Anoctamin-1 Homo sapiens 270 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509232 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509232&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348230 459279622 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067288 CC(C)(C)NC(=O)c1cccc(NC(=O)Cc2cc(F)ccc2O)c1 InChI=1S/C19H21FN2O3/c1-19(2,3)22-18(25)12-5-4-6-15(10-12)21-17(24)11-13-9-14(20)7-8-16(13)23/h4-10,23H,11H2,1-3H3,(H,21,24)(H,22,25) XWKYPWZPEMQVIE-UHFFFAOYSA-N 509233 US11364246, Example 2.1::US20200361871A1, Example 2.1 Anoctamin-1 Homo sapiens 490 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509233 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509233&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347924 459279623 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067289 CC(C)(C)NC(=O)c1cccc(NC(=O)Cc2cccc(F)c2O)c1 InChI=1S/C19H21FN2O3/c1-19(2,3)22-18(25)13-7-4-8-14(10-13)21-16(23)11-12-6-5-9-15(20)17(12)24/h4-10,24H,11H2,1-3H3,(H,21,23)(H,22,25) OOOFQVFOGVDHOJ-UHFFFAOYSA-N 509234 US11364246, Example 2.2::US20200361871A1, Example 2.2 Anoctamin-1 Homo sapiens 1610 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509234 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509234&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348138 459279624 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067290 CC(C)(C)NC(=O)c1cccc(NC(=O)Cc2ccc(F)cc2O)c1 InChI=1S/C19H21FN2O3/c1-19(2,3)22-18(25)13-5-4-6-15(9-13)21-17(24)10-12-7-8-14(20)11-16(12)23/h4-9,11,23H,10H2,1-3H3,(H,21,24)(H,22,25) BVHWTNBZUKJQKD-UHFFFAOYSA-N 509235 US11364246, Example 2.3::US20200361871A1, Example 2.3 Anoctamin-1 Homo sapiens 590 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509235 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509235&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347788 459279625 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067291 CC(C)(C)NC(=O)c1cccc(NC(=O)CCc2ccccc2O)c1 InChI=1S/C20H24N2O3/c1-20(2,3)22-19(25)15-8-6-9-16(13-15)21-18(24)12-11-14-7-4-5-10-17(14)23/h4-10,13,23H,11-12H2,1-3H3,(H,21,24)(H,22,25) DXYOAVQSWHHJGP-UHFFFAOYSA-N 509238 US11364246, Example 2.5::US20200361871A1, Example 2.5 Anoctamin-1 Homo sapiens 1340 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509238 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509238&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347803 459279628 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067292 COc1cccc(O)c1CC(=O)Nc1cccc(c1)C(=O)NC(C)(C)C InChI=1S/C20H24N2O4/c1-20(2,3)22-19(25)13-7-5-8-14(11-13)21-18(24)12-15-16(23)9-6-10-17(15)26-4/h5-11,23H,12H2,1-4H3,(H,21,24)(H,22,25) QYCBHDFTWMISBK-UHFFFAOYSA-N 509562 US11364246, Example 2.6::US20200361871A1, Example 2.6 Anoctamin-1 Homo sapiens 2910 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509562 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509562&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347780 459279941 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067293 CC(C(=O)Nc1cccc(c1)C(=O)NC(C)(C)C)c1ccccc1O InChI=1S/C20H24N2O3/c1-13(16-10-5-6-11-17(16)23)18(24)21-15-9-7-8-14(12-15)19(25)22-20(2,3)4/h5-13,23H,1-4H3,(H,21,24)(H,22,25) UGYDCHCEPFCLHV-UHFFFAOYSA-N 509563 US11364246, Example 2.7::US20200361871A1, Example 2.7 Anoctamin-1 Homo sapiens 8190 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509563 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509563&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348156 459279942 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067294 COc1cccc(CC(=O)Nc2cccc(c2)C(=O)NC(C)(C)C)c1O InChI=1S/C20H24N2O4/c1-20(2,3)22-19(25)14-8-5-9-15(11-14)21-17(23)12-13-7-6-10-16(26-4)18(13)24/h5-11,24H,12H2,1-4H3,(H,21,23)(H,22,25) OKFSTBKPTPZMJJ-UHFFFAOYSA-N 509564 US11364246, Example 2.8::US20200361871A1, Example 2.8 Anoctamin-1 Homo sapiens 4550 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509564 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509564&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348153 459279943 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067295 CC(C)(C)NC(=O)c1cccc(NC(=O)Cc2cc(F)cc(F)c2O)c1 InChI=1S/C19H20F2N2O3/c1-19(2,3)23-18(26)11-5-4-6-14(8-11)22-16(24)9-12-7-13(20)10-15(21)17(12)25/h4-8,10,25H,9H2,1-3H3,(H,22,24)(H,23,26) HYUHTGGNPYGDQS-UHFFFAOYSA-N 509565 US11364246, Example 2.9::US20200361871A1, Example 2.9 Anoctamin-1 Homo sapiens 990 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509565 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509565&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347858 459279944 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067296 CC(C)(C)NC(=O)c1cccc(NC(=O)Cc2cc(Br)ccc2O)c1 InChI=1S/C19H21BrN2O3/c1-19(2,3)22-18(25)12-5-4-6-15(10-12)21-17(24)11-13-9-14(20)7-8-16(13)23/h4-10,23H,11H2,1-3H3,(H,21,24)(H,22,25) NDALCDDUBISPIF-UHFFFAOYSA-N 509566 US11364246, Example 2.10::US20200361871A1, Example 2.10 Anoctamin-1 Homo sapiens 460 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509566 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509566&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347834 459279945 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067297 CC(C)(C)NC(=O)c1cccc(NC(=O)Cc2c(O)ccc(F)c2F)c1 InChI=1S/C19H20F2N2O3/c1-19(2,3)23-18(26)11-5-4-6-12(9-11)22-16(25)10-13-15(24)8-7-14(20)17(13)21/h4-9,24H,10H2,1-3H3,(H,22,25)(H,23,26) KYIBONBBQPNAIB-UHFFFAOYSA-N 509567 US11364246, Example 2.11::US20200361871A1, Example 2.11 Anoctamin-1 Homo sapiens 430 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509567 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509567&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347757 459279946 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067298 CC(C)(C)NC(=O)c1cccc(NC(=O)Cc2cc(F)c(F)cc2O)c1 InChI=1S/C19H20F2N2O3/c1-19(2,3)23-18(26)11-5-4-6-13(7-11)22-17(25)9-12-8-14(20)15(21)10-16(12)24/h4-8,10,24H,9H2,1-3H3,(H,22,25)(H,23,26) SFHMJQJNJXMIRJ-UHFFFAOYSA-N 509568 US11364246, Example 2.12::US20200361871A1, Example 2.12 Anoctamin-1 Homo sapiens 310 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509568 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509568&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348508 459279947 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067299 CCC(C)(C)NC(=O)c1cccc(NC(=O)Cc2ccc(F)cc2O)c1 InChI=1S/C20H23FN2O3/c1-4-20(2,3)23-19(26)14-6-5-7-16(10-14)22-18(25)11-13-8-9-15(21)12-17(13)24/h5-10,12,24H,4,11H2,1-3H3,(H,22,25)(H,23,26) PTIGAKDRVQXLSC-UHFFFAOYSA-N 509569 US11364246, Example 2.13::US20200361871A1, Example 2.13 Anoctamin-1 Homo sapiens 460 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509569 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509569&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348029 459279948 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067300 COc1ccc(CC(=O)Nc2cccc(c2)C(=O)NC(C)(C)C)c(O)c1 InChI=1S/C20H24N2O4/c1-20(2,3)22-19(25)14-6-5-7-15(10-14)21-18(24)11-13-8-9-16(26-4)12-17(13)23/h5-10,12,23H,11H2,1-4H3,(H,21,24)(H,22,25) IDOXZUPSRYLFMM-UHFFFAOYSA-N 509570 US11364246, Example 2.14::US20200361871A1, Example 2.14 Anoctamin-1 Homo sapiens 1780 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509570 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509570&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348218 459279949 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067301 CC(C)(C)NC(=O)c1cccc(NC(=O)Cc2c(O)cccc2F)c1 InChI=1S/C19H21FN2O3/c1-19(2,3)22-18(25)12-6-4-7-13(10-12)21-17(24)11-14-15(20)8-5-9-16(14)23/h4-10,23H,11H2,1-3H3,(H,21,24)(H,22,25) UCFRGXFMWJVIDP-UHFFFAOYSA-N 509571 US11364246, Example 2.15::US20200361871A1, Example 2.15 Anoctamin-1 Homo sapiens 490 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509571 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509571&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347767 459279950 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067302 CC(C)(C)NC(=O)c1cccc(NC(=O)Cc2cccc(O)c2O)c1 InChI=1S/C19H22N2O4/c1-19(2,3)21-18(25)13-7-4-8-14(10-13)20-16(23)11-12-6-5-9-15(22)17(12)24/h4-10,22,24H,11H2,1-3H3,(H,20,23)(H,21,25) SBNWTVVYKSZAIU-UHFFFAOYSA-N 509572 US11364246, Example 2.16::US20200361871A1, Example 2.16 Anoctamin-1 Homo sapiens 4270 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509572 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509572&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347899 459279951 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067303 CC(C)(C)NC(=O)c1cccc(NC(=O)Cc2cc(ccc2O)C(F)(F)F)c1 InChI=1S/C20H21F3N2O3/c1-19(2,3)25-18(28)12-5-4-6-15(10-12)24-17(27)11-13-9-14(20(21,22)23)7-8-16(13)26/h4-10,26H,11H2,1-3H3,(H,24,27)(H,25,28) XIDHZSYPBHADCH-UHFFFAOYSA-N 509573 US11364246, Example 2.17::US20200361871A1, Example 2.17 Anoctamin-1 Homo sapiens 270 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509573 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509573&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348355 459279952 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067304 COC(=O)c1ccc(O)c(CC(=O)Nc2cccc(c2)C(=O)NC(C)(C)C)c1 InChI=1S/C21H24N2O5/c1-21(2,3)23-19(26)13-6-5-7-16(11-13)22-18(25)12-15-10-14(20(27)28-4)8-9-17(15)24/h5-11,24H,12H2,1-4H3,(H,22,25)(H,23,26) BQDWZYQCKAFYNC-UHFFFAOYSA-N 509574 US11364246, Example 2.18::US20200361871A1, Example 2.18 Anoctamin-1 Homo sapiens 1410 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509574 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509574&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347930 459279953 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067305 CC(C)(C)NC(=O)c1cccc(NC(=O)Cc2ccc(cc2O)C(F)(F)F)c1 InChI=1S/C20H21F3N2O3/c1-19(2,3)25-18(28)13-5-4-6-15(9-13)24-17(27)10-12-7-8-14(11-16(12)26)20(21,22)23/h4-9,11,26H,10H2,1-3H3,(H,24,27)(H,25,28) XWUXJSIESYEASY-UHFFFAOYSA-N 509575 US11364246, Example 2.19::US20200361871A1, Example 2.19 Anoctamin-1 Homo sapiens 460 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509575 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509575&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347840 459279954 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067306 CC(C)(C)NC(=O)c1cc(NC(=O)Cc2cc(Cl)ccc2O)ccn1 InChI=1S/C18H20ClN3O3/c1-18(2,3)22-17(25)14-10-13(6-7-20-14)21-16(24)9-11-8-12(19)4-5-15(11)23/h4-8,10,23H,9H2,1-3H3,(H,22,25)(H,20,21,24) LRZSWIFZQPMUIM-UHFFFAOYSA-N 509576 N-tert-Butyl-4-[[2-(5-chloro-2-hydroxy-phenyl)acetyl]amino]pyridine-2-carboxamide::US11364246, Example 3::US20200361871A1, Example 3 Anoctamin-1 Homo sapiens 110 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509576 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509576&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347879 459279955 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067307 CCC(C)(C)NC(=O)c1cc(NC(=O)Cc2ccc(F)cc2O)ccn1 InChI=1S/C19H22FN3O3/c1-4-19(2,3)23-18(26)15-11-14(7-8-21-15)22-17(25)9-12-5-6-13(20)10-16(12)24/h5-8,10-11,24H,4,9H2,1-3H3,(H,23,26)(H,21,22,25) YPGIINZAKMKCMK-UHFFFAOYSA-N 509577 US11364246, Example 3.1a::US20200361871A1, Example 3.1a Anoctamin-1 Homo sapiens 180 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509577 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509577&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347796 459279956 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067308 CC(C)(C)NC(=O)c1cc(NC(=O)Cc2ccc(F)cc2O)ccn1 InChI=1S/C18H20FN3O3/c1-18(2,3)22-17(25)14-10-13(6-7-20-14)21-16(24)8-11-4-5-12(19)9-15(11)23/h4-7,9-10,23H,8H2,1-3H3,(H,22,25)(H,20,21,24) CQBTZLAYHWXQHT-UHFFFAOYSA-N 509578 US11364246, Example 3.2a::US20200361871A1, Example 3.2a Anoctamin-1 Homo sapiens 160 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509578 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509578&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348517 459279957 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067309 CC(C)(C)NC(=O)c1cc(NC(=O)Cc2c(O)cccc2Cl)ccn1 InChI=1S/C18H20ClN3O3/c1-18(2,3)22-17(25)14-9-11(7-8-20-14)21-16(24)10-12-13(19)5-4-6-15(12)23/h4-9,23H,10H2,1-3H3,(H,22,25)(H,20,21,24) CUPOIIRQHUAOAN-UHFFFAOYSA-N 509579 US11364246, Example 3.3a::US20200361871A1, Example 3.3a Anoctamin-1 Homo sapiens 70.0 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509579 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509579&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348127 459279958 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067310 CC(C)(C)NC(=O)c1cc(NC(=O)Cc2cc(Cl)c(Br)cc2O)ccn1 InChI=1S/C18H19BrClN3O3/c1-18(2,3)23-17(26)14-8-11(4-5-21-14)22-16(25)7-10-6-13(20)12(19)9-15(10)24/h4-6,8-9,24H,7H2,1-3H3,(H,23,26)(H,21,22,25) FDRTWBIJXRIBSI-UHFFFAOYSA-N 509580 US11364246, Example 3.4a::US20200361871A1, Example 3.4a Anoctamin-1 Homo sapiens 140 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509580 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509580&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348212 459279959 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067311 CC(C)(C)c1ccc(O)c(CC(=O)Nc2ccnc(c2)C(=O)NC2(CCC2)C#N)c1 InChI=1S/C23H26N4O3/c1-22(2,3)16-5-6-19(28)15(11-16)12-20(29)26-17-7-10-25-18(13-17)21(30)27-23(14-24)8-4-9-23/h5-7,10-11,13,28H,4,8-9,12H2,1-3H3,(H,27,30)(H,25,26,29) SFELPGLFQFFXSE-UHFFFAOYSA-N 509581 US11364246, Example 3.5a::US20200361871A1, Example 3.5a Anoctamin-1 Homo sapiens 500 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509581 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509581&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348522 459279960 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067312 CC(C)(C)c1ccc(O)c(CC(=O)Nc2ccnc(c2)C(=O)NC2(C)CCC2)c1 InChI=1S/C23H29N3O3/c1-22(2,3)16-6-7-19(27)15(12-16)13-20(28)25-17-8-11-24-18(14-17)21(29)26-23(4)9-5-10-23/h6-8,11-12,14,27H,5,9-10,13H2,1-4H3,(H,26,29)(H,24,25,28) XDDZBUNHYDDZTR-UHFFFAOYSA-N 509583 US11364246, Example 3.6a::US20200361871A1, Example 3.6a Anoctamin-1 Homo sapiens 370 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509583 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509583&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347815 459279961 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067313 CC(C)(C)NC(=O)c1cc(NC(=O)Cc2c(O)c(Br)cc(F)c2Br)ccn1 InChI=1S/C18H18Br2FN3O3/c1-18(2,3)24-17(27)13-6-9(4-5-22-13)23-14(25)7-10-15(20)12(21)8-11(19)16(10)26/h4-6,8,26H,7H2,1-3H3,(H,24,27)(H,22,23,25) QVPMNNHYKMBBQE-UHFFFAOYSA-N 509584 US11364246, Example 3.7a::US20200361871A1, Example 3.7a Anoctamin-1 Homo sapiens 280 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509584 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509584&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347829 459279962 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067314 CC(C)(C)NC(=O)c1cc(NC(=O)Cc2cc(ccc2O)C(F)(F)F)ccn1 InChI=1S/C19H20F3N3O3/c1-18(2,3)25-17(28)14-10-13(6-7-23-14)24-16(27)9-11-8-12(19(20,21)22)4-5-15(11)26/h4-8,10,26H,9H2,1-3H3,(H,25,28)(H,23,24,27) YZVLORSIDFYNME-UHFFFAOYSA-N 509585 N-tert-Butyl-4-[[2-[2-hydroxy-5-(trifluoromethyl)phenyl]acetyl]amino]pyridine-2-carboxamide::US11364246, Example 3.5b::US20200361871A1, Example 3.5b Anoctamin-1 Homo sapiens 200 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509585 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509585&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347812 459279963 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067315 CC(C)(C)NC(=O)c1cc(NC(=O)Cc2ccc(Cl)cc2O)ccn1 InChI=1S/C18H20ClN3O3/c1-18(2,3)22-17(25)14-10-13(6-7-20-14)21-16(24)8-11-4-5-12(19)9-15(11)23/h4-7,9-10,23H,8H2,1-3H3,(H,22,25)(H,20,21,24) NJUKDBGNUAQNFQ-UHFFFAOYSA-N 509586 US11364246, Example 3.6b::US20200361871A1, Example 3.6b Anoctamin-1 Homo sapiens 120 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509586 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509586&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348454 459279964 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067316 CC(C)(C)NC(=O)c1cc(NC(=O)Cc2ccc(cc2O)C(F)(F)F)ccn1 InChI=1S/C19H20F3N3O3/c1-18(2,3)25-17(28)14-10-13(6-7-23-14)24-16(27)8-11-4-5-12(9-15(11)26)19(20,21)22/h4-7,9-10,26H,8H2,1-3H3,(H,25,28)(H,23,24,27) PBJYXFCVEIVMEV-UHFFFAOYSA-N 509587 US11364246, Example 3.7b::US20200361871A1, Example 3.7b Anoctamin-1 Homo sapiens 180 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509587 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509587&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348269 459279965 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067317 COc1ccc(O)c(CC(=O)Nc2ccnc(c2)C(=O)NC(C)(C)C)c1 InChI=1S/C19H23N3O4/c1-19(2,3)22-18(25)15-11-13(7-8-20-15)21-17(24)10-12-9-14(26-4)5-6-16(12)23/h5-9,11,23H,10H2,1-4H3,(H,22,25)(H,20,21,24) HVSXKEAGSCJSIA-UHFFFAOYSA-N 509588 US11364246, Example 3.8b::US20200361871A1, Example 3.8b Anoctamin-1 Homo sapiens 300 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509588 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509588&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347843 459279966 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067318 CC(C)(C)NC(=O)c1cc(NC(=O)C2CCc3ccc(O)cc23)ccn1 InChI=1S/C20H23N3O3/c1-20(2,3)23-19(26)17-10-13(8-9-21-17)22-18(25)15-7-5-12-4-6-14(24)11-16(12)15/h4,6,8-11,15,24H,5,7H2,1-3H3,(H,23,26)(H,21,22,25) RAIHYJSFZXTTHN-UHFFFAOYSA-N 509589 US11364246, Example 3.9b::US20200361871A1, Example 3.9b Anoctamin-1 Homo sapiens 960 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509589 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509589&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348037 459279967 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067319 CC(C)(C)NC(=O)c1cc(NC(=O)C2CCc3cccc(O)c23)ccn1 InChI=1S/C20H23N3O3/c1-20(2,3)23-19(26)15-11-13(9-10-21-15)22-18(25)14-8-7-12-5-4-6-16(24)17(12)14/h4-6,9-11,14,24H,7-8H2,1-3H3,(H,23,26)(H,21,22,25) KUXQDUOPOFRFRM-UHFFFAOYSA-N 509590 US11364246, Example 3.10b::US20200361871A1, Example 3.10b Anoctamin-1 Homo sapiens 460 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509590 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509590&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347921 459279968 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067320 CC(C)(C)NC(=O)c1cc(NC(=O)Cc2c(O)c(Br)cc(Cl)c2Br)ccn1 InChI=1S/C18H18Br2ClN3O3/c1-18(2,3)24-17(27)13-6-9(4-5-22-13)23-14(25)7-10-15(20)12(21)8-11(19)16(10)26/h4-6,8,26H,7H2,1-3H3,(H,24,27)(H,22,23,25) KNWDCLYFEABRPL-UHFFFAOYSA-N 509591 US11364246, Example 3.11b::US20200361871A1, Example 3.11b Anoctamin-1 Homo sapiens 410 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509591 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509591&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347756 459279969 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067321 CC(C)(C)NC(=O)c1cc(NC(=O)Cc2cccc(O)c2)ccn1 InChI=1S/C18H21N3O3/c1-18(2,3)21-17(24)15-11-13(7-8-19-15)20-16(23)10-12-5-4-6-14(22)9-12/h4-9,11,22H,10H2,1-3H3,(H,21,24)(H,19,20,23) YLLGWSZPARQUTJ-UHFFFAOYSA-N 509592 US11364246, Example 3.12b::US20200361871A1, Example 3.12b Anoctamin-1 Homo sapiens 340 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509592 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509592&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347800 459279970 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067322 CC(C)(C)NC(=O)c1cc(NC(=O)Cc2cc(O)ccc2F)ccn1 InChI=1S/C18H20FN3O3/c1-18(2,3)22-17(25)15-10-12(6-7-20-15)21-16(24)9-11-8-13(23)4-5-14(11)19/h4-8,10,23H,9H2,1-3H3,(H,22,25)(H,20,21,24) ZLJONSLCQHLFOB-UHFFFAOYSA-N 509593 US11364246, Example 3.13b::US20200361871A1, Example 3.13b Anoctamin-1 Homo sapiens 250 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509593 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509593&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347958 459279971 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067323 CC(C)(C)NC(=O)c1cc(NC(=O)Cc2ccc(Cl)c(O)c2)ccn1 InChI=1S/C18H20ClN3O3/c1-18(2,3)22-17(25)14-10-12(6-7-20-14)21-16(24)9-11-4-5-13(19)15(23)8-11/h4-8,10,23H,9H2,1-3H3,(H,22,25)(H,20,21,24) LADFFVDSUHVUFB-UHFFFAOYSA-N 509594 US11364246, Example 3.14b::US20200361871A1, Example 3.14b Anoctamin-1 Homo sapiens 40.0 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509594 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509594&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347932 459279972 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067324 CC(C)(C)NC(=O)c1cc(NC(=O)Cc2cc(O)ccc2Cl)ccn1 InChI=1S/C18H20ClN3O3/c1-18(2,3)22-17(25)15-10-12(6-7-20-15)21-16(24)9-11-8-13(23)4-5-14(11)19/h4-8,10,23H,9H2,1-3H3,(H,22,25)(H,20,21,24) BYFYZVMXYSUFOV-UHFFFAOYSA-N 509595 US11364246, Example 3.16b::US20200361871A1, Example 3.16b Anoctamin-1 Homo sapiens 170 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509595 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509595&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348327 459279973 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067325 CC(C)(C)NC(=O)c1cc(NC(=O)Cc2cc(O)cc(Cl)c2)ccn1 InChI=1S/C18H20ClN3O3/c1-18(2,3)22-17(25)15-10-13(4-5-20-15)21-16(24)8-11-6-12(19)9-14(23)7-11/h4-7,9-10,23H,8H2,1-3H3,(H,22,25)(H,20,21,24) RPLUCODBISHJSV-UHFFFAOYSA-N 509596 US11364246, Example 3.17b::US20200361871A1, Example 3.17b Anoctamin-1 Homo sapiens 120 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509596 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509596&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348087 459279974 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067326 CC(C)(C)NC(=O)c1cccc(NC(=O)Cc2cccc(O)c2)c1 InChI=1S/C19H22N2O3/c1-19(2,3)21-18(24)14-7-5-8-15(12-14)20-17(23)11-13-6-4-9-16(22)10-13/h4-10,12,22H,11H2,1-3H3,(H,20,23)(H,21,24) LYDLVTPAEZLHIQ-UHFFFAOYSA-N 509597 N-tert-Butyl-3-[[2-[3-hydroxyphenyl]acetyl]amino]benzamide::US11364246, Example 4::US20200361871A1, Example 4 Anoctamin-1 Homo sapiens 1500 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509597 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509597&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347854 459279975 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067327 CC(C)(C)NC(=O)c1cccc(NC(=O)Cc2n[nH]c3ccccc23)c1 InChI=1S/C20H22N4O2/c1-20(2,3)22-19(26)13-7-6-8-14(11-13)21-18(25)12-17-15-9-4-5-10-16(15)23-24-17/h4-11H,12H2,1-3H3,(H,21,25)(H,22,26)(H,23,24) HTLNGVOUHWERPD-UHFFFAOYSA-N 509598 US11364246, Example 4.1::US20200361871A1, Example 4.1 Anoctamin-1 Homo sapiens 2170 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509598 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509598&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 49380105 459279976 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067328 CC(C)(C)NC(=O)c1cccc(NC(=O)Cc2c[nH]c3ccc(F)cc23)c1 InChI=1S/C21H22FN3O2/c1-21(2,3)25-20(27)13-5-4-6-16(9-13)24-19(26)10-14-12-23-18-8-7-15(22)11-17(14)18/h4-9,11-12,23H,10H2,1-3H3,(H,24,26)(H,25,27) KLJDGLHJWCSWFE-UHFFFAOYSA-N 509599 US20200361871A1, Example 4.2 Anoctamin-1 Homo sapiens 660 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509599 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509599&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347802 459279977 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067329 CC(C)(C)NC(=O)c1cccc(NC(=O)Cc2ccccc2O)c1 InChI=1S/C19H22N2O3/c1-19(2,3)21-18(24)14-8-6-9-15(11-14)20-17(23)12-13-7-4-5-10-16(13)22/h4-11,22H,12H2,1-3H3,(H,20,23)(H,21,24) LBEJVNUEZQHYLG-UHFFFAOYSA-N 509600 US11364246, Example 4.3::US20200361871A1, Example 4.3 Anoctamin-1 Homo sapiens 1530 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509600 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509600&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348229 459279978 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067330 Cc1[nH]c2c(F)cccc2c1CC(=O)Nc1cccc(c1)C(=O)NC(C)(C)C InChI=1S/C22H24FN3O2/c1-13-17(16-9-6-10-18(23)20(16)24-13)12-19(27)25-15-8-5-7-14(11-15)21(28)26-22(2,3)4/h5-11,24H,12H2,1-4H3,(H,25,27)(H,26,28) QSFYUBUFVNIKOR-UHFFFAOYSA-N 509601 US11364246, Example 4.4::US20200361871A1, Example 4.4 Anoctamin-1 Homo sapiens 4190 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509601 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509601&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347708 459279979 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067331 CC(C)(C)NC(=O)c1cccc(NC(=O)Cc2c[nH]c3ccccc23)c1 InChI=1S/C21H23N3O2/c1-21(2,3)24-20(26)14-7-6-8-16(11-14)23-19(25)12-15-13-22-18-10-5-4-9-17(15)18/h4-11,13,22H,12H2,1-3H3,(H,23,25)(H,24,26) ZNKYTEOJVPRZSM-UHFFFAOYSA-N 509602 US11364246, Example 4.5::US20200361871A1, Example 4.5 Anoctamin-1 Homo sapiens 700 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509602 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509602&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348179 459279980 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067332 CC(C)(C)NC(=O)c1cccc(NC(=O)Cc2ccccc2)c1 InChI=1S/C19H22N2O2/c1-19(2,3)21-18(23)15-10-7-11-16(13-15)20-17(22)12-14-8-5-4-6-9-14/h4-11,13H,12H2,1-3H3,(H,20,22)(H,21,23) ATPCQXCINMFCGQ-UHFFFAOYSA-N 509603 US11364246, Example 4.6::US20200361871A1, Example 4.6 Anoctamin-1 Homo sapiens 3860 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509603 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509603&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 49956923 459279981 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067333 COc1ccc(F)c(F)c1CC(=O)Nc1cccc(c1)C(=O)NC(C)(C)C InChI=1S/C20H22F2N2O3/c1-20(2,3)24-19(26)12-6-5-7-13(10-12)23-17(25)11-14-16(27-4)9-8-15(21)18(14)22/h5-10H,11H2,1-4H3,(H,23,25)(H,24,26) NJHUPADVFJWCIX-UHFFFAOYSA-N 509604 US11364246, Example 4.8::US20200361871A1, Example 4.8 Anoctamin-1 Homo sapiens 2070 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509604 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509604&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347868 459279982 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067334 COc1cc(ccc1CC(=O)Nc1cccc(c1)C(=O)NC(C)(C)C)C(F)(F)F InChI=1S/C21H23F3N2O3/c1-20(2,3)26-19(28)14-6-5-7-16(10-14)25-18(27)11-13-8-9-15(21(22,23)24)12-17(13)29-4/h5-10,12H,11H2,1-4H3,(H,25,27)(H,26,28) QPGLWDXFCMPIGZ-UHFFFAOYSA-N 509605 US11364246, Example 4.9::US20200361871A1, Example 4.9 Anoctamin-1 Homo sapiens 4660 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509605 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509605&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348125 459279983 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067335 CC(C)(C)NC(=O)c1cc(NC(=O)Cc2cccs2)ccn1 InChI=1S/C16H19N3O2S/c1-16(2,3)19-15(21)13-9-11(6-7-17-13)18-14(20)10-12-5-4-8-22-12/h4-9H,10H2,1-3H3,(H,19,21)(H,17,18,20) JWAGBUOKBGTMEV-UHFFFAOYSA-N 509606 N-tert-Butyl-4-[[2-[2-thienyl]acetyl]amino]pyridine-2-carboxamide::US11364246, Example 5::US20200361871A1, Example 5 Anoctamin-1 Homo sapiens 800 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509606 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509606&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347728 459279984 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067336 CC(C)(C)NC(=O)c1cc(NC(=O)CC2C3CC4CC(C3)CC2C4)ccn1 InChI=1S/C22H31N3O2/c1-22(2,3)25-21(27)19-11-17(4-5-23-19)24-20(26)12-18-15-7-13-6-14(9-15)10-16(18)8-13/h4-5,11,13-16,18H,6-10,12H2,1-3H3,(H,25,27)(H,23,24,26) IEJOFZZSRUSQCV-UHFFFAOYSA-N 509607 4-[[2-(2-Adamantyl)acetyl]amino]-N-tert-butyl-pyridine-2-carboxamide::US11364246, Example 5.1::US20200361871A1, Example 5.1 Anoctamin-1 Homo sapiens 870 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509607 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509607&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348504 459279985 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067337 CC(C)(C)NC(=O)c1cc(NC(=O)Cc2cc(Cl)ccc2F)ccn1 InChI=1S/C18H19ClFN3O2/c1-18(2,3)23-17(25)15-10-13(6-7-21-15)22-16(24)9-11-8-12(19)4-5-14(11)20/h4-8,10H,9H2,1-3H3,(H,23,25)(H,21,22,24) ZGZCIQMHZUGYAR-UHFFFAOYSA-N 509608 US11364246, Example 5.3::US20200361871A1, Example 5.3 Anoctamin-1 Homo sapiens 880 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509608 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509608&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347928 459279986 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067338 CC(C)(C)NC(=O)c1cc(NC(=O)Cc2cccc(Cl)c2)ccn1 InChI=1S/C18H20ClN3O2/c1-18(2,3)22-17(24)15-11-14(7-8-20-15)21-16(23)10-12-5-4-6-13(19)9-12/h4-9,11H,10H2,1-3H3,(H,22,24)(H,20,21,23) ATEPHMKTMLCDIO-UHFFFAOYSA-N 509609 US11364246, Example 5.5::US20200361871A1, Example 5.5 Anoctamin-1 Homo sapiens 720 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509609 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509609&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347927 459279987 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067339 CC(C)(C)NC(=O)c1cc(NC(=O)Cc2c[nH]c3ccccc23)ccn1 InChI=1S/C20H22N4O2/c1-20(2,3)24-19(26)17-11-14(8-9-21-17)23-18(25)10-13-12-22-16-7-5-4-6-15(13)16/h4-9,11-12,22H,10H2,1-3H3,(H,24,26)(H,21,23,25) SFQXNKWSAGYBQW-UHFFFAOYSA-N 509610 US11364246, Example 5.6::US20200361871A1, Example 5.6 Anoctamin-1 Homo sapiens 150 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509610 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509610&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348448 459279988 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067340 Cc1ccccc1CC(=O)Nc1ccnc(c1)C(=O)NC(C)(C)C InChI=1S/C19H23N3O2/c1-13-7-5-6-8-14(13)11-17(23)21-15-9-10-20-16(12-15)18(24)22-19(2,3)4/h5-10,12H,11H2,1-4H3,(H,22,24)(H,20,21,23) KMTCBBDQYSHVNF-UHFFFAOYSA-N 509611 US11364246, Example 5.7::US20200361871A1, Example 5.7 Anoctamin-1 Homo sapiens 1230 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509611 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509611&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348078 459279989 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067341 CC(C)(C)NC(=O)c1cc(NC(=O)Cc2ccc(Cl)c(Cl)c2)ccn1 InChI=1S/C18H19Cl2N3O2/c1-18(2,3)23-17(25)15-10-12(6-7-21-15)22-16(24)9-11-4-5-13(19)14(20)8-11/h4-8,10H,9H2,1-3H3,(H,23,25)(H,21,22,24) FQSFWGIMIHAZNK-UHFFFAOYSA-N 509612 US11364246, Example 5.8::US20200361871A1, Example 5.8 Anoctamin-1 Homo sapiens 460 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509612 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509612&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348426 459279990 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067342 CC(C)(C)NC(=O)c1cc(NC(=O)Cc2cccc(F)c2)ccn1 InChI=1S/C18H20FN3O2/c1-18(2,3)22-17(24)15-11-14(7-8-20-15)21-16(23)10-12-5-4-6-13(19)9-12/h4-9,11H,10H2,1-3H3,(H,22,24)(H,20,21,23) BYFPUAUTVWXBSS-UHFFFAOYSA-N 509613 US11364246, Example 5.9::US20200361871A1, Example 5.9 Anoctamin-1 Homo sapiens 1130 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509613 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509613&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348076 459279991 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067343 COc1ccc(Cl)cc1CC(=O)Nc1ccnc(c1)C(=O)NC(C)(C)C InChI=1S/C19H22ClN3O3/c1-19(2,3)23-18(25)15-11-14(7-8-21-15)22-17(24)10-12-9-13(20)5-6-16(12)26-4/h5-9,11H,10H2,1-4H3,(H,23,25)(H,21,22,24) PPVWHOIIFPDYNZ-UHFFFAOYSA-N 509614 US11364246, Example 5.10::US20200361871A1, Example 5.10 Anoctamin-1 Homo sapiens 3770 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509614 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509614&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139366824 459279992 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067344 Cc1ccc(CC(=O)Nc2ccnc(c2)C(=O)NC(C)(C)C)cc1 InChI=1S/C19H23N3O2/c1-13-5-7-14(8-6-13)11-17(23)21-15-9-10-20-16(12-15)18(24)22-19(2,3)4/h5-10,12H,11H2,1-4H3,(H,22,24)(H,20,21,23) QEESCULJIAWVOJ-UHFFFAOYSA-N 509615 US11364246, Example 5.11::US20200361871A1, Example 5.11 Anoctamin-1 Homo sapiens 170 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509615 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509615&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347783 459279993 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067345 CC(C)(C)NC(=O)c1cc(NC(=O)Cc2ccccc2F)ccn1 InChI=1S/C18H20FN3O2/c1-18(2,3)22-17(24)15-11-13(8-9-20-15)21-16(23)10-12-6-4-5-7-14(12)19/h4-9,11H,10H2,1-3H3,(H,22,24)(H,20,21,23) OSEZIFYWGZSBAG-UHFFFAOYSA-N 509616 US11364246, Example 5.12::US20200361871A1, Example 5.12 Anoctamin-1 Homo sapiens 760 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509616 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509616&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347718 459279994 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067346 CC(C)(C)NC(=O)c1cc(NC(=O)Cc2ccc(F)cc2)ccn1 InChI=1S/C18H20FN3O2/c1-18(2,3)22-17(24)15-11-14(8-9-20-15)21-16(23)10-12-4-6-13(19)7-5-12/h4-9,11H,10H2,1-3H3,(H,22,24)(H,20,21,23) FSUDWWJZZRXMDP-UHFFFAOYSA-N 509617 US11364246, Example 5.13::US20200361871A1, Example 5.13 Anoctamin-1 Homo sapiens 1140 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509617 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509617&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348123 459279995 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067347 Cc1cccc(CC(=O)Nc2ccnc(c2)C(=O)NC(C)(C)C)c1 InChI=1S/C19H23N3O2/c1-13-6-5-7-14(10-13)11-17(23)21-15-8-9-20-16(12-15)18(24)22-19(2,3)4/h5-10,12H,11H2,1-4H3,(H,22,24)(H,20,21,23) VGLGCVJIEBTBIH-UHFFFAOYSA-N 509618 US11364246, Example 5.14::US20200361871A1, Example 5.14 Anoctamin-1 Homo sapiens 760 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509618 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509618&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347781 459279996 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067348 CC(C)(C)NC(=O)c1cc(NC(=O)Cc2c(Cl)cccc2Cl)ccn1 InChI=1S/C18H19Cl2N3O2/c1-18(2,3)23-17(25)15-9-11(7-8-21-15)22-16(24)10-12-13(19)5-4-6-14(12)20/h4-9H,10H2,1-3H3,(H,23,25)(H,21,22,24) LOHQIRXGOMYNEA-UHFFFAOYSA-N 509619 US11364246, Example 5.17::US20200361871A1, Example 5.17 Anoctamin-1 Homo sapiens 650 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509619 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509619&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347810 459279997 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067349 CC(C)(C)NC(=O)c1cc(NC(=O)Cc2ccc(Cl)c(F)c2)ccn1 InChI=1S/C18H19ClFN3O2/c1-18(2,3)23-17(25)15-10-12(6-7-21-15)22-16(24)9-11-4-5-13(19)14(20)8-11/h4-8,10H,9H2,1-3H3,(H,23,25)(H,21,22,24) WLUZVAAXXXVEOR-UHFFFAOYSA-N 509620 US11364246, Example 5.18::US20200361871A1, Example 5.18 Anoctamin-1 Homo sapiens 460 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509620 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509620&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348280 459279998 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067350 CC(C)(C)NC(=O)c1cc(NC(=O)Cc2cc(Cl)cc(Cl)c2)ccn1 InChI=1S/C18H19Cl2N3O2/c1-18(2,3)23-17(25)15-10-14(4-5-21-15)22-16(24)8-11-6-12(19)9-13(20)7-11/h4-7,9-10H,8H2,1-3H3,(H,23,25)(H,21,22,24) IUBSSKSCLLEUOB-UHFFFAOYSA-N 509621 US11364246, Example 5.19::US20200361871A1, Example 5.19 Anoctamin-1 Homo sapiens 1850 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509621 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509621&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347703 459279999 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067351 CC(C)(C)NC(=O)c1cc(NC(=O)Cc2ccccc2Cl)ccn1 InChI=1S/C18H20ClN3O2/c1-18(2,3)22-17(24)15-11-13(8-9-20-15)21-16(23)10-12-6-4-5-7-14(12)19/h4-9,11H,10H2,1-3H3,(H,22,24)(H,20,21,23) JAXMNSMBOXGRND-UHFFFAOYSA-N 509622 US11364246, Example 5.20::US20200361871A1, Example 5.20 Anoctamin-1 Homo sapiens 570 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509622 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509622&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347806 459280000 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067352 CC(C)(C)NC(=O)c1cc(NC(=O)Cc2ccc(O)c(Cl)c2)ccn1 InChI=1S/C18H20ClN3O3/c1-18(2,3)22-17(25)14-10-12(6-7-20-14)21-16(24)9-11-4-5-15(23)13(19)8-11/h4-8,10,23H,9H2,1-3H3,(H,22,25)(H,20,21,24) AWDAJHSQMMKQIJ-UHFFFAOYSA-N 509623 US11364246, Example 5.21::US20200361871A1, Example 5.21 Anoctamin-1 Homo sapiens 510 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509623 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509623&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347753 459280001 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067353 CC(C)(C)NC(=O)c1cc(NC(=O)Cc2ccc3nccnc3c2)ccn1 InChI=1S/C20H21N5O2/c1-20(2,3)25-19(27)17-12-14(6-7-21-17)24-18(26)11-13-4-5-15-16(10-13)23-9-8-22-15/h4-10,12H,11H2,1-3H3,(H,25,27)(H,21,24,26) XLZLWGOLLPAXGI-UHFFFAOYSA-N 509624 US11364246, Example 5.23::US20200361871A1, Example 5.23 Anoctamin-1 Homo sapiens 1200 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509624 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509624&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347864 459280002 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067354 CC(C)(C)NC(=O)c1cc(NC(=O)Cc2ccc3ccccc3c2)ccn1 InChI=1S/C22H23N3O2/c1-22(2,3)25-21(27)19-14-18(10-11-23-19)24-20(26)13-15-8-9-16-6-4-5-7-17(16)12-15/h4-12,14H,13H2,1-3H3,(H,25,27)(H,23,24,26) FNMMCGQCWNYNJM-UHFFFAOYSA-N 509625 US11364246, Example 5.24::US20200361871A1, Example 5.24 Anoctamin-1 Homo sapiens 140 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509625 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509625&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348103 459280003 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067355 CC(C)(C)NC(=O)c1cc(NC(=O)C2CCCCc3ccccc23)ccn1 InChI=1S/C22H27N3O2/c1-22(2,3)25-21(27)19-14-16(12-13-23-19)24-20(26)18-11-7-5-9-15-8-4-6-10-17(15)18/h4,6,8,10,12-14,18H,5,7,9,11H2,1-3H3,(H,25,27)(H,23,24,26) KSTHFQZXDBIRBB-UHFFFAOYSA-N 509626 US11364246, Example 5.26::US20200361871A1, Example 5.26 Anoctamin-1 Homo sapiens 1200 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509626 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509626&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347730 459280004 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067356 CC(C)(C)NC(=O)c1cc(NC(=O)Cc2ccc3ncccc3c2)ccn1 InChI=1S/C21H22N4O2/c1-21(2,3)25-20(27)18-13-16(8-10-23-18)24-19(26)12-14-6-7-17-15(11-14)5-4-9-22-17/h4-11,13H,12H2,1-3H3,(H,25,27)(H,23,24,26) KNDNWXWEVGTKLD-UHFFFAOYSA-N 509627 US11364246, Example 5.29::US20200361871A1, Example 5.29 Anoctamin-1 Homo sapiens 860 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509627 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509627&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347739 459280005 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067357 CC(C)(NC(=O)c1cc(NC(=O)CC2CCC(F)(F)CC2)ccn1)C#C InChI=1S/C19H23F2N3O2/c1-4-18(2,3)24-17(26)15-12-14(7-10-22-15)23-16(25)11-13-5-8-19(20,21)9-6-13/h1,7,10,12-13H,5-6,8-9,11H2,2-3H3,(H,24,26)(H,22,23,25) WZHCADRFVURYCT-UHFFFAOYSA-N 509628 4-[[2-(4,4-Difluorocyclohexyl)acetyl]amino]-N-(1,1-dimethylprop-2-ynyl)pyridine-2-carboxamide::US11364246, Example 5.34::US20200361871A1, Example 5.34 Anoctamin-1 Homo sapiens 640 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509628 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509628&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348057 459280006 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067358 CC(C)(NC(=O)c1cc(NC(=O)Cc2ccc(cc2)C(F)(F)F)ccn1)C#C InChI=1S/C20H18F3N3O2/c1-4-19(2,3)26-18(28)16-12-15(9-10-24-16)25-17(27)11-13-5-7-14(8-6-13)20(21,22)23/h1,5-10,12H,11H2,2-3H3,(H,26,28)(H,24,25,27) UOBWALYQABEDJC-UHFFFAOYSA-N 509629 N-(1,1-Dimethylprop-2-ynyl)-4-[[2-[4-(trifluoromethyl)phenyl]acetyl]amino]pyridine-2-carboxamide::US11364246, Example 5.35::US20200361871A1, Example 5.35 Anoctamin-1 Homo sapiens 180 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509629 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509629&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347734 459280007 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067359 CC(C)(NC(=O)c1cc(NC(=O)Cc2c[nH]nc2C(F)(F)F)ccn1)C#C InChI=1S/C17H16F3N5O2/c1-4-16(2,3)24-15(27)12-8-11(5-6-21-12)23-13(26)7-10-9-22-25-14(10)17(18,19)20/h1,5-6,8-9H,7H2,2-3H3,(H,22,25)(H,24,27)(H,21,23,26) VMRHHDOMDZADQW-UHFFFAOYSA-N 509630 N-(1,1-Dimethylprop-2-ynyl)-4-[[2-[3-(trifluoromethyl)-1H-pyrazol-4-yl]acetyl] amino] pyridine-2-carboxamide::US11364246, Example 5.36::US20200361871A1, Example 5.36 Anoctamin-1 Homo sapiens 60.0 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509630 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509630&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348425 459280008 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067360 CC(C)(NC(=O)c1cc(NC(=O)Cc2cccc(c2)C(F)(F)F)ccn1)C#C InChI=1S/C20H18F3N3O2/c1-4-19(2,3)26-18(28)16-12-15(8-9-24-16)25-17(27)11-13-6-5-7-14(10-13)20(21,22)23/h1,5-10,12H,11H2,2-3H3,(H,26,28)(H,24,25,27) KCJKBDSDWQWVCR-UHFFFAOYSA-N 509631 N-(1,1-Dimethylprop-2-ynyl)-4-[[2-[3-(trifluoromethyl)phenyl]acetyl]amino]pyridine-2-carboxamide::US11364246, Example 5.37::US20200361871A1, Example 5.37 Anoctamin-1 Homo sapiens 150 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509631 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509631&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347722 459280009 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067361 CC(C)(NC(=O)c1cc(NC(=O)Cc2ccccc2C(F)(F)F)ccn1)C#C InChI=1S/C20H18F3N3O2/c1-4-19(2,3)26-18(28)16-12-14(9-10-24-16)25-17(27)11-13-7-5-6-8-15(13)20(21,22)23/h1,5-10,12H,11H2,2-3H3,(H,26,28)(H,24,25,27) PHTTVZOPMJLJKL-UHFFFAOYSA-N 509632 N-(1,1-Dimethylprop-2-ynyl)-4-[[2-[2-(trifluoromethyl)phenyl]acetyl]amino]pyridine-2-carboxamide::US11364246, Example 5.38::US20200361871A1, Example 5.38 Anoctamin-1 Homo sapiens 150 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509632 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509632&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348510 459280010 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067362 CC(C)(C)NC(=O)c1cc(NC(=O)Cc2cc(ccc2O)C#N)ccn1 InChI=1S/C19H20N4O3/c1-19(2,3)23-18(26)15-10-14(6-7-21-15)22-17(25)9-13-8-12(11-20)4-5-16(13)24/h4-8,10,24H,9H2,1-3H3,(H,23,26)(H,21,22,25) HUNDZHDWKYYCGW-UHFFFAOYSA-N 509633 N-tert-Butyl-4-[[2-(5-cyano-2-hydroxy-phenyl)acetyl]amino]pyridine-2-carboxamide::US11364246, Example 6::US20200361871A1, Example 6 Anoctamin-1 Homo sapiens 1140 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509633 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509633&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347855 459280011 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067363 CC(C)(C)C(C)(C)NC(=O)c1cccc(NC(=O)Cc2cc(Cl)ccc2O)c1 InChI=1S/C22H27ClN2O3/c1-21(2,3)22(4,5)25-20(28)14-7-6-8-17(12-14)24-19(27)13-15-11-16(23)9-10-18(15)26/h6-12,26H,13H2,1-5H3,(H,24,27)(H,25,28) SRSZOQGRMLIGLD-UHFFFAOYSA-N 509634 3-[[2-(5-Chloro-2-hydroxy-phenyl)acetyl]amino]-N-(1,1,2,2-tetramethylpropyl) benzamide::US11364246, Example 7::US20200361871A1, Example 7 Anoctamin-1 Homo sapiens 650 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509634 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509634&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347770 459280012 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067364 CCCC(C)(C)NC(=O)c1cccc(NC(=O)Cc2cc(Cl)ccc2O)c1 InChI=1S/C21H25ClN2O3/c1-4-10-21(2,3)24-20(27)14-6-5-7-17(12-14)23-19(26)13-15-11-16(22)8-9-18(15)25/h5-9,11-12,25H,4,10,13H2,1-3H3,(H,23,26)(H,24,27) DWINTOWNDKDZND-UHFFFAOYSA-N 509635 US11364246, Example 7.1::US20200361871A1, Example 7.1 Anoctamin-1 Homo sapiens 340 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509635 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509635&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347827 459280013 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067365 CCCC(C)(C)NC(=O)c1cc(NC(=O)Cc2cc(Cl)ccc2O)ccn1 InChI=1S/C20H24ClN3O3/c1-4-8-20(2,3)24-19(27)16-12-15(7-9-22-16)23-18(26)11-13-10-14(21)5-6-17(13)25/h5-7,9-10,12,25H,4,8,11H2,1-3H3,(H,24,27)(H,22,23,26) MVPGACRQEHMLNY-UHFFFAOYSA-N 509636 US11364246, Example 7.2::US20200361871A1, Example 7.2 Anoctamin-1 Homo sapiens 260 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509636 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509636&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347713 459280014 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067366 Oc1ccc(Cl)cc1CC(=O)Nc1cccc(c1)C(=O)NC1CCCCC1 InChI=1S/C21H23ClN2O3/c22-16-9-10-19(25)15(11-16)13-20(26)23-18-8-4-5-14(12-18)21(27)24-17-6-2-1-3-7-17/h4-5,8-12,17,25H,1-3,6-7,13H2,(H,23,26)(H,24,27) CYTHUVVGMIQJML-UHFFFAOYSA-N 509637 US11364246, Example 7.3::US20200361871A1, Example 7.3 Anoctamin-1 Homo sapiens 200 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509637 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509637&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348505 459280015 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067367 Oc1ccc(Cl)cc1CC(=O)Nc1cccc(c1)C(=O)NC1CCOCC1 InChI=1S/C20H21ClN2O4/c21-15-4-5-18(24)14(10-15)12-19(25)22-17-3-1-2-13(11-17)20(26)23-16-6-8-27-9-7-16/h1-5,10-11,16,24H,6-9,12H2,(H,22,25)(H,23,26) GZRBRTKEDPJYBO-UHFFFAOYSA-N 509638 US11364246, Example 7.4::US20200361871A1, Example 7.4 Anoctamin-1 Homo sapiens 650 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509638 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509638&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 150380675 459280016 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067368 CC(C)C(C)(C)NC(=O)c1cccc(NC(=O)Cc2cc(Cl)ccc2O)c1 InChI=1S/C21H25ClN2O3/c1-13(2)21(3,4)24-20(27)14-6-5-7-17(11-14)23-19(26)12-15-10-16(22)8-9-18(15)25/h5-11,13,25H,12H2,1-4H3,(H,23,26)(H,24,27) QPCDYOJHINZSLA-UHFFFAOYSA-N 509639 US11364246, Example 7.5::US20200361871A1, Example 7.5 Anoctamin-1 Homo sapiens 280 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509639 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509639&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347795 459280017 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067369 CC(C)C(C)(C)NC(=O)c1cc(NC(=O)Cc2cc(Cl)ccc2O)ccn1 InChI=1S/C20H24ClN3O3/c1-12(2)20(3,4)24-19(27)16-11-15(7-8-22-16)23-18(26)10-13-9-14(21)5-6-17(13)25/h5-9,11-12,25H,10H2,1-4H3,(H,24,27)(H,22,23,26) HYKPBRHFHZQADS-UHFFFAOYSA-N 509640 US11364246, Example 7.6::US20200361871A1, Example 7.6 Anoctamin-1 Homo sapiens 100.0 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509640 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509640&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347735 459280018 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067370 CC(C)NC(=O)c1cc(NC(=O)Cc2cc(Cl)ccc2O)ccn1 InChI=1S/C17H18ClN3O3/c1-10(2)20-17(24)14-9-13(5-6-19-14)21-16(23)8-11-7-12(18)3-4-15(11)22/h3-7,9-10,22H,8H2,1-2H3,(H,20,24)(H,19,21,23) ZTUQNYQVIAQRLD-UHFFFAOYSA-N 509641 US11364246, Example 7.7::US20200361871A1, Example 7.7 Anoctamin-1 Homo sapiens 130 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509641 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509641&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348380 459280019 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067371 CC1(CCOCC1)NC(=O)c1cccc(NC(=O)Cc2cc(Cl)ccc2O)c1 InChI=1S/C21H23ClN2O4/c1-21(7-9-28-10-8-21)24-20(27)14-3-2-4-17(12-14)23-19(26)13-15-11-16(22)5-6-18(15)25/h2-6,11-12,25H,7-10,13H2,1H3,(H,23,26)(H,24,27) ANSRWVCLFVGMFF-UHFFFAOYSA-N 509642 US11364246, Example 7.8::US20200361871A1, Example 7.8 Anoctamin-1 Homo sapiens 920 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509642 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509642&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348142 459280020 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067372 CC1(CCOCC1)NC(=O)c1cc(NC(=O)Cc2cc(Cl)ccc2O)ccn1 InChI=1S/C20H22ClN3O4/c1-20(5-8-28-9-6-20)24-19(27)16-12-15(4-7-22-16)23-18(26)11-13-10-14(21)2-3-17(13)25/h2-4,7,10,12,25H,5-6,8-9,11H2,1H3,(H,24,27)(H,22,23,26) ZAFFLFWOSJVCKM-UHFFFAOYSA-N 509643 US11364246, Example 7.9::US20200361871A1, Example 7.9 Anoctamin-1 Homo sapiens 230 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509643 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509643&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348271 459280021 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067373 CC1(CCC1)NC(=O)c1cccc(NC(=O)Cc2cc(Cl)ccc2O)c1 InChI=1S/C20H21ClN2O3/c1-20(8-3-9-20)23-19(26)13-4-2-5-16(11-13)22-18(25)12-14-10-15(21)6-7-17(14)24/h2,4-7,10-11,24H,3,8-9,12H2,1H3,(H,22,25)(H,23,26) TXXARUWBVPWVSA-UHFFFAOYSA-N 509644 US11364246, Example 7.10::US20200361871A1, Example 7.10 Anoctamin-1 Homo sapiens 360 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509644 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509644&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348241 459280022 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067374 Oc1ccc(Cl)cc1CC(=O)Nc1ccnc(c1)C(=O)NC1CCOCC1 InChI=1S/C19H20ClN3O4/c20-13-1-2-17(24)12(9-13)10-18(25)22-15-3-6-21-16(11-15)19(26)23-14-4-7-27-8-5-14/h1-3,6,9,11,14,24H,4-5,7-8,10H2,(H,23,26)(H,21,22,25) IPTLKIVAPZMCCN-UHFFFAOYSA-N 509645 US11364246, Example 7.11::US20200361871A1, Example 7.11 Anoctamin-1 Homo sapiens 320 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509645 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509645&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347814 459280023 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067375 O[C@H]1CC[C@H](CC1)NC(=O)c1cc(NC(=O)Cc2cc(Cl)ccc2O)ccn1 InChI=1S/C20H22ClN3O4/c21-13-1-6-18(26)12(9-13)10-19(27)23-15-7-8-22-17(11-15)20(28)24-14-2-4-16(25)5-3-14/h1,6-9,11,14,16,25-26H,2-5,10H2,(H,24,28)(H,22,23,27)/t14-,16+ BOJFJLXQCYSVEU-FZNQNYSPSA-N 509646 US11364246, Example 7.12::US20200361871A1, Example 7.12 Anoctamin-1 Homo sapiens 2110 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509646 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509646&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347777 459280024 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067376 CCC(C)NC(=O)c1cc(NC(=O)Cc2cc(Cl)ccc2O)ccn1 InChI=1S/C18H20ClN3O3/c1-3-11(2)21-18(25)15-10-14(6-7-20-15)22-17(24)9-12-8-13(19)4-5-16(12)23/h4-8,10-11,23H,3,9H2,1-2H3,(H,21,25)(H,20,22,24) WIDGOZCCBMDNBR-UHFFFAOYSA-N 509647 US11364246, Example 7.13::US20200361871A1, Example 7.13 Anoctamin-1 Homo sapiens 90.0 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509647 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509647&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347838 459280025 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067377 CC(C)(O)C(C)(C)NC(=O)c1cc(NC(=O)Cc2cc(Cl)ccc2O)ccn1 InChI=1S/C20H24ClN3O4/c1-19(2,20(3,4)28)24-18(27)15-11-14(7-8-22-15)23-17(26)10-12-9-13(21)5-6-16(12)25/h5-9,11,25,28H,10H2,1-4H3,(H,24,27)(H,22,23,26) KLZOUEZKYACUGU-UHFFFAOYSA-N 509648 US11364246, Example 7.14::US20200361871A1, Example 7.14 Anoctamin-1 Homo sapiens 150 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509648 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509648&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348159 459280026 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067378 Oc1ccc(Cl)cc1CC(=O)Nc1ccnc(c1)C(=O)NC12CC(C1)C2 InChI=1S/C19H18ClN3O3/c20-13-1-2-16(24)12(5-13)6-17(25)22-14-3-4-21-15(7-14)18(26)23-19-8-11(9-19)10-19/h1-5,7,11,24H,6,8-10H2,(H,23,26)(H,21,22,25) GIPCQXOXJUFMLY-UHFFFAOYSA-N 509649 US11364246, Example 7.15::US20200361871A1, Example 7.15 Anoctamin-1 Homo sapiens 50.0 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509649 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509649&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348515 459280027 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067379 Oc1ccc(Cl)cc1CC(=O)Nc1ccnc(c1)C(=O)NC1(CCC1)C#N InChI=1S/C19H17ClN4O3/c20-13-2-3-16(25)12(8-13)9-17(26)23-14-4-7-22-15(10-14)18(27)24-19(11-21)5-1-6-19/h2-4,7-8,10,25H,1,5-6,9H2,(H,24,27)(H,22,23,26) CTKLFBPQRXUTFM-UHFFFAOYSA-N 509650 US11364246, Example 7.16::US20200361871A1, Example 7.16 Anoctamin-1 Homo sapiens 130 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509650 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509650&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348055 459280028 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067380 CC(C)(C)OC(=O)N1CCCC(C1)NC(=O)c1cccc(NC(=O)Cc2cc(Cl)ccc2O)c1 InChI=1S/C25H30ClN3O5/c1-25(2,3)34-24(33)29-11-5-8-20(15-29)28-23(32)16-6-4-7-19(13-16)27-22(31)14-17-12-18(26)9-10-21(17)30/h4,6-7,9-10,12-13,20,30H,5,8,11,14-15H2,1-3H3,(H,27,31)(H,28,32) CFGLMJDALFVGMO-UHFFFAOYSA-N 509651 US11364246, Example 8::US20200361871A1, Example 8::tert-Butyl-3-[[3-[[2-(5-chloro-2-hydroxy-phenyl)acetyl]amino]benzoyl]amino] piperidine-1-carboxylate Anoctamin-1 Homo sapiens 3020 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509651 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509651&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348261 459280029 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067381 CC(C)(C)OC(=O)N1CCCC(C1)NC(=O)c1cc(NC(=O)Cc2cc(Cl)ccc2O)ccn1 InChI=1S/C24H29ClN4O5/c1-24(2,3)34-23(33)29-10-4-5-18(14-29)28-22(32)19-13-17(8-9-26-19)27-21(31)12-15-11-16(25)6-7-20(15)30/h6-9,11,13,18,30H,4-5,10,12,14H2,1-3H3,(H,28,32)(H,26,27,31) HWRVGUBXZXIIQS-UHFFFAOYSA-N 509652 US11364246, Example 8.1::US20200361871A1, Example 8.1::tert-Butyl-3-[[4-[[2-(5-chloro-2-hydroxy-phenyl)acetyl]amino]pyridine-2-carbonyl]amino]piperidine-1-carboxylate Anoctamin-1 Homo sapiens 590 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509652 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509652&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347754 459280030 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067382 CC(C)(C)OC(=O)N1CCC(C)(CC1)NC(=O)c1cccc(NC(=O)Cc2cc(Cl)ccc2O)c1 InChI=1S/C26H32ClN3O5/c1-25(2,3)35-24(34)30-12-10-26(4,11-13-30)29-23(33)17-6-5-7-20(15-17)28-22(32)16-18-14-19(27)8-9-21(18)31/h5-9,14-15,31H,10-13,16H2,1-4H3,(H,28,32)(H,29,33) WGTCYHDVXLPDQS-UHFFFAOYSA-N 509653 US20200361871A1, Example 8.2 Anoctamin-1 Homo sapiens 1960 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509653 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509653&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 152258062 459280031 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067383 CC(C)(C)OC(=O)N1C[C@H]2[C@@H](C1)[C@@H]2NC(=O)c1cc(NC(=O)Cc2cc(Cl)ccc2O)ccn1 InChI=1S/C24H27ClN4O5/c1-24(2,3)34-23(33)29-11-16-17(12-29)21(16)28-22(32)18-10-15(6-7-26-18)27-20(31)9-13-8-14(25)4-5-19(13)30/h4-8,10,16-17,21,30H,9,11-12H2,1-3H3,(H,28,32)(H,26,27,31)/t16-,17+,21+ PWNZVNKYMMCJTI-LFUKPOHLSA-N 509654 US11364246, Example 8.3::US20200361871A1, Example 8.3 Anoctamin-1 Homo sapiens 230 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509654 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509654&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 155317094 459280032 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067384 CC(C)(C)NC(=O)c1ccc(F)c(NC(=O)Cc2cc(Cl)ccc2O)c1 InChI=1S/C19H20ClFN2O3/c1-19(2,3)23-18(26)11-4-6-14(21)15(9-11)22-17(25)10-12-8-13(20)5-7-16(12)24/h4-9,24H,10H2,1-3H3,(H,22,25)(H,23,26) MJJJSCCVGDNTQE-UHFFFAOYSA-N 509655 N-tert-Butyl-3-[[2-(5-chloro-2-hydroxy-phenyl)acetyl]amino]-4-fluoro-benzamide::US11364246, Example 9::US20200361871A1, Example 9 Anoctamin-1 Homo sapiens 230 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509655 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509655&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347723 459280033 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067385 Cc1cc(NC(=O)Cc2cc(Cl)ccc2O)cc(c1)C(=O)NC(C)(C)C InChI=1S/C20H23ClN2O3/c1-12-7-14(19(26)23-20(2,3)4)10-16(8-12)22-18(25)11-13-9-15(21)5-6-17(13)24/h5-10,24H,11H2,1-4H3,(H,22,25)(H,23,26) IVOSAIOIOOCWRP-UHFFFAOYSA-N 509656 N-tert-Butyl-3-[[2-(5-chloro-2-hydroxy-phenyl)acetyl]amino]-5-methyl-benzamide::US11364246, Example 9.1::US20200361871A1, Example 9.1 Anoctamin-1 Homo sapiens 4620 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509656 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509656&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348409 459280034 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067386 CCC(C)(C)NC(=O)c1cc(NC(=O)Cc2cc(Cl)ccc2O)ccn1 InChI=1S/C19H22ClN3O3/c1-4-19(2,3)23-18(26)15-11-14(7-8-21-15)22-17(25)10-12-9-13(20)5-6-16(12)24/h5-9,11,24H,4,10H2,1-3H3,(H,23,26)(H,21,22,25) KBSNNEGEKXPBIY-UHFFFAOYSA-N 509657 4-[[2-(5-Chloro-2-hydroxy-phenyl)acetyl]amino]-N-(1,1-dimethylpropyl)pyridine-2-carboxamide::US11364246, Example 9.2::US20200361871A1, Example 9.2 Anoctamin-1 Homo sapiens 190 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509657 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509657&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348503 459280035 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067387 CC(C)(C)NC(=O)c1cc(NC(=O)Cc2cc(ccc2O)C(C)(C)C)ccn1 InChI=1S/C22H29N3O3/c1-21(2,3)15-7-8-18(26)14(11-15)12-19(27)24-16-9-10-23-17(13-16)20(28)25-22(4,5)6/h7-11,13,26H,12H2,1-6H3,(H,25,28)(H,23,24,27) KHVSLIXNCJYBLV-UHFFFAOYSA-N 509658 N-tert-Butyl-4-[[2-(5-tert-butyl-2-hydroxy-phenyl)acetyl]amino]pyridine-2-carboxamide::US11364246, Example 10::US20200361871A1, Example 10 Anoctamin-1 Homo sapiens 220 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509658 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509658&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348290 459280036 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067388 CC(C)(C)NC(=O)c1cc(NC(=O)Cc2cc(Cl)ccc2O)ccc1O InChI=1S/C19H21ClN2O4/c1-19(2,3)22-18(26)14-10-13(5-7-16(14)24)21-17(25)9-11-8-12(20)4-6-15(11)23/h4-8,10,23-24H,9H2,1-3H3,(H,21,25)(H,22,26) NRDWFVYRSWLEHD-UHFFFAOYSA-N 509659 N-tert-Butyl-5-[[2-(5-chloro-2-hydroxy-phenyl)acetyl]amino]-2-hydroxy-benzamide::US11364246, Example 11::US20200361871A1, Example 11 Anoctamin-1 Homo sapiens 900 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509659 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509659&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347729 459280037 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067389 CC(C)(C)NC(=O)c1cccc(NC(=O)Cc2cc(ccc2O)C#N)c1 InChI=1S/C20H21N3O3/c1-20(2,3)23-19(26)14-5-4-6-16(10-14)22-18(25)11-15-9-13(12-21)7-8-17(15)24/h4-10,24H,11H2,1-3H3,(H,22,25)(H,23,26) WQCKDERENMEESH-UHFFFAOYSA-N 509660 N-tert-Butyl-3-[[2-(5-cyano-2-hydroxy-phenyl)acetyl]amino] benzamide::US11364246, Example 12::US20200361871A1, Example 12 Anoctamin-1 Homo sapiens 1760 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509660 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509660&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347746 459280038 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067390 COC(=O)c1ccc(O)c(CC(=O)Nc2ccnc(c2)C(=O)NC(C)(C)C)c1 InChI=1S/C20H23N3O5/c1-20(2,3)23-18(26)15-11-14(7-8-21-15)22-17(25)10-13-9-12(19(27)28-4)5-6-16(13)24/h5-9,11,24H,10H2,1-4H3,(H,23,26)(H,21,22,25) JYNLGWPCZOXRSQ-UHFFFAOYSA-N 509661 Methyl 3-[2-[[2-(tert-butylcarbamoyl)-4-pyridyl]amino]-2-oxo-ethyl]-4-hydroxy-benzoate::US11364246, Example 13::US20200361871A1, Example 13 Anoctamin-1 Homo sapiens 1000 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509661 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509661&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348178 459280039 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067391 Cc1ccc(O)c(CC(=O)Nc2ccnc(c2)C(=O)NC(C)(C)C)c1 InChI=1S/C19H23N3O3/c1-12-5-6-16(23)13(9-12)10-17(24)21-14-7-8-20-15(11-14)18(25)22-19(2,3)4/h5-9,11,23H,10H2,1-4H3,(H,22,25)(H,20,21,24) VWOYELSHVZOHGW-UHFFFAOYSA-N 509662 N-tert-Butyl-4-[[2-(2-hydroxy-5-methyl-phenyl)acetyl]amino]pyridine-2-carboxamide::US11364246, Example 15::US20200361871A1, Example 15 Anoctamin-1 Homo sapiens 130 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509662 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509662&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348091 459280040 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067392 CC(C)(C)NC(=O)c1cc(NC(=O)Cc2cc(Cl)ccc2O)ccc1F InChI=1S/C19H20ClFN2O3/c1-19(2,3)23-18(26)14-10-13(5-6-15(14)21)22-17(25)9-11-8-12(20)4-7-16(11)24/h4-8,10,24H,9H2,1-3H3,(H,22,25)(H,23,26) PEZFQUNMGCXABE-UHFFFAOYSA-N 509663 N-tert-Butyl-5-[[2-(5-chloro-2-hydroxy-phenyl)acetyl]amino]-2-fluoro-benzamide::US11364246, Example 17::US20200361871A1, Example 17 Anoctamin-1 Homo sapiens 1490 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509663 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509663&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348334 459280041 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067393 CC(C)(C)NC(=O)c1cc(F)cc(NC(=O)Cc2cc(Cl)ccc2O)c1 InChI=1S/C19H20ClFN2O3/c1-19(2,3)23-18(26)12-7-14(21)10-15(8-12)22-17(25)9-11-6-13(20)4-5-16(11)24/h4-8,10,24H,9H2,1-3H3,(H,22,25)(H,23,26) CHINRINRGDKHGR-UHFFFAOYSA-N 509664 N-tert-Butyl-3-[[2-(5-chloro-2-hydroxy-phenyl)acetyl]amino]-5-fluoro-benzamide::US11364246, Example 18::US20200361871A1, Example 18 Anoctamin-1 Homo sapiens 450 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509664 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509664&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348006 459280042 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067394 CC(C)(C)NC(=O)c1cc(NC(=O)Cc2cc(F)ccc2O)ccn1 InChI=1S/C18H20FN3O3/c1-18(2,3)22-17(25)14-10-13(6-7-20-14)21-16(24)9-11-8-12(19)4-5-15(11)23/h4-8,10,23H,9H2,1-3H3,(H,22,25)(H,20,21,24) PTTBXQSZHFHCRU-UHFFFAOYSA-N 509665 N-tert-Butyl-4-[[2-(5-fluoro-2-hydroxy-phenyl)acetyl]amino]pyridine-2-carboxamide::US11364246, Example 20::US20200361871A1, Example 20 Anoctamin-1 Homo sapiens 220 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509665 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509665&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347934 459280043 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067395 CC(C)(C)NC(=O)c1cc(NC(=O)[C@H]2CCc3ccccc23)ccn1 InChI=1S/C20H23N3O2/c1-20(2,3)23-19(25)17-12-14(10-11-21-17)22-18(24)16-9-8-13-6-4-5-7-15(13)16/h4-7,10-12,16H,8-9H2,1-3H3,(H,23,25)(H,21,22,24)/t16-/m0/s1 DYYVLRDDKMHNIC-INIZCTEOSA-N 509666 US11364246, Example 21a::US20200361871A1, Example 21a Anoctamin-1 Homo sapiens 1570 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509666 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509666&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348412 459280044 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067396 CC(C)(C)NC(=O)c1cc(NC(=O)C2CCc3ccccc23)ccn1 InChI=1S/C20H23N3O2/c1-20(2,3)23-19(25)17-12-14(10-11-21-17)22-18(24)16-9-8-13-6-4-5-7-15(13)16/h4-7,10-12,16H,8-9H2,1-3H3,(H,23,25)(H,21,22,24) DYYVLRDDKMHNIC-UHFFFAOYSA-N 509667 US11364246, Example 21b::US20200361871A1, Example 21b Anoctamin-1 Homo sapiens 1080 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509667 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509667&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347831 459280045 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067397 CC(C)(NC(=O)c1cc(NC(=O)CC2CCCC2)ccn1)C#C InChI=1S/C18H23N3O2/c1-4-18(2,3)21-17(23)15-12-14(9-10-19-15)20-16(22)11-13-7-5-6-8-13/h1,9-10,12-13H,5-8,11H2,2-3H3,(H,21,23)(H,19,20,22) RJMGCZVEGSVRIA-UHFFFAOYSA-N 509668 4-[(2-Cyclopentylacetyl)amino]-N-(1,1-dimethylprop-2-ynyl)pyridine-2-carboxamide::US11364246, Example 22.2::US20200361871A1, Example 22.2 Anoctamin-1 Homo sapiens 260 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509668 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509668&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347790 459280046 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067398 CC(C)(C)NC(=O)c1cc(NC(=O)C2Cc3ccccc3C2)ccn1 InChI=1S/C20H23N3O2/c1-20(2,3)23-19(25)17-12-16(8-9-21-17)22-18(24)15-10-13-6-4-5-7-14(13)11-15/h4-9,12,15H,10-11H2,1-3H3,(H,23,25)(H,21,22,24) JVYKNOUEHRIMRF-UHFFFAOYSA-N 509669 US11364246, Example 23.3::US20200361871A1, Example 23.3 Anoctamin-1 Homo sapiens 470 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509669 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509669&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347944 459280047 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067399 CC(C)(C)NC(=O)c1cc(NC(=O)Cc2ccccc2C(F)(F)F)ccn1 InChI=1S/C19H20F3N3O2/c1-18(2,3)25-17(27)15-11-13(8-9-23-15)24-16(26)10-12-6-4-5-7-14(12)19(20,21)22/h4-9,11H,10H2,1-3H3,(H,25,27)(H,23,24,26) CZRNVAVOPVOTGE-UHFFFAOYSA-N 509670 US11364246, Example 23.12::US20200361871A1, Example 23.12 Anoctamin-1 Homo sapiens 330 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509670 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509670&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347913 459280048 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067400 CC(C)(C)NC(=O)c1cc(NC(=O)Cc2ccccc2Br)ccn1 InChI=1S/C18H20BrN3O2/c1-18(2,3)22-17(24)15-11-13(8-9-20-15)21-16(23)10-12-6-4-5-7-14(12)19/h4-9,11H,10H2,1-3H3,(H,22,24)(H,20,21,23) MBNOBRSQXQXRJI-UHFFFAOYSA-N 509671 US11364246, Example 23.13::US20200361871A1, Example 23.13 Anoctamin-1 Homo sapiens 570 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509671 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509671&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347898 459280049 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067401 Clc1ccccc1CC(=O)Nc1ccnc(c1)C(=O)NC1(CCOCC1)C#N InChI=1S/C20H19ClN4O3/c21-16-4-2-1-3-14(16)11-18(26)24-15-5-8-23-17(12-15)19(27)25-20(13-22)6-9-28-10-7-20/h1-5,8,12H,6-7,9-11H2,(H,25,27)(H,23,24,26) LMRLNQXCNVNKRZ-UHFFFAOYSA-N 509672 US11364246, Example 23.15::US20200361871A1, Example 23.15 Anoctamin-1 Homo sapiens 1190 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509672 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509672&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 150963956 459280050 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067402 O=C(Cc1ccc2ncccc2c1)Nc1ccnc(c1)C(=O)NC1(CCOCC1)C#N InChI=1S/C23H21N5O3/c24-15-23(6-10-31-11-7-23)28-22(30)20-14-18(5-9-26-20)27-21(29)13-16-3-4-19-17(12-16)2-1-8-25-19/h1-5,8-9,12,14H,6-7,10-11,13H2,(H,28,30)(H,26,27,29) DTYHGBJQHJIGJW-UHFFFAOYSA-N 509673 US11364246, Example 23.16::US20200361871A1, Example 23.16 Anoctamin-1 Homo sapiens 1400 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509673 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509673&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347848 459280051 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067403 CC(C)(C)c1ccc(O)c(CC(=O)Nc2ccnc(c2)C(=O)NC23CC(C2)C3)c1 InChI=1S/C23H27N3O3/c1-22(2,3)16-4-5-19(27)15(8-16)9-20(28)25-17-6-7-24-18(10-17)21(29)26-23-11-14(12-23)13-23/h4-8,10,14,27H,9,11-13H2,1-3H3,(H,26,29)(H,24,25,28) ADLLEZBWIQWWQR-UHFFFAOYSA-N 509674 N-(3-Bicyclo[1.1.1]pentanyl)-4-[[2-(5-tert-butyl-2-hydroxy-phenyl)acetyl]amino] pyridine-2-carboxamide::US11364246, Example 25::US20200361871A1, Example 25 Anoctamin-1 Homo sapiens 370 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509674 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509674&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348108 459280052 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067404 CC(C)(C)c1ccc(O)c(CC(=O)Nc2ccnc(c2)C(=O)NC2(CCOCC2)C#N)c1 InChI=1S/C24H28N4O4/c1-23(2,3)17-4-5-20(29)16(12-17)13-21(30)27-18-6-9-26-19(14-18)22(31)28-24(15-25)7-10-32-11-8-24/h4-6,9,12,14,29H,7-8,10-11,13H2,1-3H3,(H,28,31)(H,26,27,30) BVPQTSRXUWEDDS-UHFFFAOYSA-N 509675 4-[[2-(5-tert-Butyl-2-hydroxy-phenyl)acetyl]amino]-N-(4-cyanotetrahydropyran-4-yl)pyridine-2-carboxamide::US11364246, Example 25.1::US20200361871A1, Example 25.1 Anoctamin-1 Homo sapiens 140 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509675 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509675&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348554 459280053 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067405 CC(C)(C)NC(=O)c1cc(NC(=O)Cc2cc(Cl)c(CN3CCC(F)(F)C3)cc2O)ccn1 InChI=1S/C23H27ClF2N4O3/c1-22(2,3)29-21(33)18-11-16(4-6-27-18)28-20(32)10-14-8-17(24)15(9-19(14)31)12-30-7-5-23(25,26)13-30/h4,6,8-9,11,31H,5,7,10,12-13H2,1-3H3,(H,29,33)(H,27,28,32) ATLYUYSKSQTWNE-UHFFFAOYSA-N 509676 US11364246, Example 27.3::US20200361871A1, Example 27.3 Anoctamin-1 Homo sapiens 290 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509676 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509676&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348333 459280054 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067406 CC(C)(C)NC(=O)c1cc(NC(=O)Cc2cc(Cl)ccc2O)c(F)cn1 InChI=1S/C18H19ClFN3O3/c1-18(2,3)23-17(26)14-8-13(12(20)9-21-14)22-16(25)7-10-6-11(19)4-5-15(10)24/h4-6,8-9,24H,7H2,1-3H3,(H,23,26)(H,21,22,25) CEPVGHGTXVKIAM-UHFFFAOYSA-N 509677 N-tert-butyl-4-[[2-(5-chloro-2-hydroxy-phenyl)acetyl]amino]-5-fluoro-pyridine-2-carboxamide::US11364246, Example 28::US20200361871A1, Example 28 Anoctamin-1 Homo sapiens 400 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509677 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509677&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347784 459280055 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067407 Clc1ccccc1CC(=O)Nc1ccnc(c1)C(=O)NC1(CCC1)C#N InChI=1S/C19H17ClN4O2/c20-15-5-2-1-4-13(15)10-17(25)23-14-6-9-22-16(11-14)18(26)24-19(12-21)7-3-8-19/h1-2,4-6,9,11H,3,7-8,10H2,(H,24,26)(H,22,23,25) MUGUPGKLYMWILZ-UHFFFAOYSA-N 509678 4-[[2-(2-Chlorophenyl)acetyl]amino]-N-(1-cyanocyclobutyl)pyridine-2-carboxamide::US11364246, Example 30.11::US20200361871A1, Example 30::US20200361871A1, Example 30.11::US20200361871A1, Example 30.13 Anoctamin-1 Homo sapiens 1220 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509678 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509678&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348017 459280056 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067408 CC(C)(NC(=O)c1cc(NC(=O)Cc2ccccc2Cl)ccn1)C#C InChI=1S/C19H18ClN3O2/c1-4-19(2,3)23-18(25)16-12-14(9-10-21-16)22-17(24)11-13-7-5-6-8-15(13)20/h1,5-10,12H,11H2,2-3H3,(H,23,25)(H,21,22,24) MCYUGDNSPYFUQI-UHFFFAOYSA-N 509679 4-[[2-(2-Chlorophenyl)acetyl]amino]-N-(1,1-dimethylprop-2-ynyl)pyridine-2-carboxamide::US11364246, Example 30.1::US20200361871A1, Example 30.1 Anoctamin-1 Homo sapiens 140 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509679 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509679&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348170 459280057 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067409 FC12CC(C1)(CC2)NC(=O)c1cc(NC(=O)Cc2ccccc2Cl)ccn1 InChI=1S/C20H19ClFN3O2/c21-15-4-2-1-3-13(15)9-17(26)24-14-5-8-23-16(10-14)18(27)25-20-7-6-19(22,11-20)12-20/h1-5,8,10H,6-7,9,11-12H2,(H,25,27)(H,23,24,26) IAASQRMFNOIXLE-UHFFFAOYSA-N 509680 4-[[2-(2-Chlorophenyl)acetyl]amino]-N-(4-fluoro-1-bicyclo[2.1.1]hexanyl)pyridine-2-carboxamide::US11364246, Example 30.2::US20200361871A1, Example 30.2 Anoctamin-1 Homo sapiens 180 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509680 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509680&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348365 459280058 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067410 CC(C)(NC(=O)c1cc(NC(=O)Cc2ccccc2Cl)ccn1)C1CC1 InChI=1S/C20H22ClN3O2/c1-20(2,14-7-8-14)24-19(26)17-12-15(9-10-22-17)23-18(25)11-13-5-3-4-6-16(13)21/h3-6,9-10,12,14H,7-8,11H2,1-2H3,(H,24,26)(H,22,23,25) BQJIYHUNKOQKNY-UHFFFAOYSA-N 509681 4-[[2-(2-Chlorophenyl)acetyl]amino]-N-(1-cyclopropyl-1-methyl-ethyl)pyridine-2-carboxamide::US11364246, Example 30.3::US20200361871A1, Example 30.3 Anoctamin-1 Homo sapiens 250 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509681 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509681&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347807 459280059 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067411 CC12CC(C1)(C2)NC(=O)c1cc(NC(=O)Cc2ccccc2Cl)ccn1 InChI=1S/C20H20ClN3O2/c1-19-10-20(11-19,12-19)24-18(26)16-9-14(6-7-22-16)23-17(25)8-13-4-2-3-5-15(13)21/h2-7,9H,8,10-12H2,1H3,(H,24,26)(H,22,23,25) IXDHDQWNUZFWAH-UHFFFAOYSA-N 509682 US11364246, Example 30.4::US20200361871A1, Example 30.4 Anoctamin-1 Homo sapiens 750 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509682 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509682&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347789 459280060 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067412 Clc1ccccc1CC(=O)Nc1ccnc(c1)C(=O)NC1(CC1)C#N InChI=1S/C18H15ClN4O2/c19-14-4-2-1-3-12(14)9-16(24)22-13-5-8-21-15(10-13)17(25)23-18(11-20)6-7-18/h1-5,8,10H,6-7,9H2,(H,23,25)(H,21,22,24) XLUUTDMNRPNOLK-UHFFFAOYSA-N 509683 US11364246, Example 30.7::US20200361871A1, Example 30.7 Anoctamin-1 Homo sapiens 340 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509683 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509683&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 152412875 459280061 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067413 CC1(CC1)NC(=O)c1cc(NC(=O)Cc2ccccc2Cl)ccn1 InChI=1S/C18H18ClN3O2/c1-18(7-8-18)22-17(24)15-11-13(6-9-20-15)21-16(23)10-12-4-2-3-5-14(12)19/h2-6,9,11H,7-8,10H2,1H3,(H,22,24)(H,20,21,23) NVDIBSRQYMOUGY-UHFFFAOYSA-N 509684 US11364246, Example 30.8::US20200361871A1, Example 30.8 Anoctamin-1 Homo sapiens 700 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509684 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509684&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348422 459280062 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067414 FC12CC(C1)(C2)NC(=O)c1cc(NC(=O)Cc2ccccc2Cl)ccn1 InChI=1S/C19H17ClFN3O2/c20-14-4-2-1-3-12(14)7-16(25)23-13-5-6-22-15(8-13)17(26)24-19-9-18(21,10-19)11-19/h1-6,8H,7,9-11H2,(H,24,26)(H,22,23,25) IQDKPIQLVAKAIP-UHFFFAOYSA-N 509685 US11364246, Example 30.9::US20200361871A1, Example 30.9 Anoctamin-1 Homo sapiens 470 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509685 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509685&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347860 459280063 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067415 Clc1ccccc1CC(=O)Nc1ccnc(c1)C(=O)NC1(CCC1)C#N InChI=1S/C19H17ClN4O2/c20-15-5-2-1-4-13(15)10-17(25)23-14-6-9-22-16(11-14)18(26)24-19(12-21)7-3-8-19/h1-2,4-6,9,11H,3,7-8,10H2,(H,24,26)(H,22,23,25) MUGUPGKLYMWILZ-UHFFFAOYSA-N 509678 4-[[2-(2-Chlorophenyl)acetyl]amino]-N-(1-cyanocyclobutyl)pyridine-2-carboxamide::US11364246, Example 30.11::US20200361871A1, Example 30::US20200361871A1, Example 30.11::US20200361871A1, Example 30.13 Anoctamin-1 Homo sapiens 220 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509678 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509678&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348017 459280056 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067416 Clc1ccccc1CC(=O)Nc1ccnc(c1)C(=O)NC1(CCC1)C#N InChI=1S/C19H17ClN4O2/c20-15-5-2-1-4-13(15)10-17(25)23-14-6-9-22-16(11-14)18(26)24-19(12-21)7-3-8-19/h1-2,4-6,9,11H,3,7-8,10H2,(H,24,26)(H,22,23,25) MUGUPGKLYMWILZ-UHFFFAOYSA-N 509678 4-[[2-(2-Chlorophenyl)acetyl]amino]-N-(1-cyanocyclobutyl)pyridine-2-carboxamide::US11364246, Example 30.11::US20200361871A1, Example 30::US20200361871A1, Example 30.11::US20200361871A1, Example 30.13 Anoctamin-1 Homo sapiens 380 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509678 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509678&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348017 459280056 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067417 Oc1ccc(Cl)cc1CC(=O)Nc1ccnc(c1)C(=O)NC1(CCOCC1)C#N InChI=1S/C20H19ClN4O4/c21-14-1-2-17(26)13(9-14)10-18(27)24-15-3-6-23-16(11-15)19(28)25-20(12-22)4-7-29-8-5-20/h1-3,6,9,11,26H,4-5,7-8,10H2,(H,25,28)(H,23,24,27) QXLCCQLDHASOPP-UHFFFAOYSA-N 509688 4-[[2-(5-Chloro-2-hydroxy-phenyl)acetyl]amino]-N-(4-cyanotetrahydropyran-4-yl)pyridine-2-carboxamide::US11364246, Example 31::US20200361871A1, Example 31 Anoctamin-1 Homo sapiens 120 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509688 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509688&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347712 459280064 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067418 Oc1ccc(Cl)cc1CC(=O)Nc1ccnc(c1)C(=O)NC1(CCCC1)C#C InChI=1S/C21H20ClN3O3/c1-2-21(8-3-4-9-21)25-20(28)17-13-16(7-10-23-17)24-19(27)12-14-11-15(22)5-6-18(14)26/h1,5-7,10-11,13,26H,3-4,8-9,12H2,(H,25,28)(H,23,24,27) AMNQVNDYEXJAGW-UHFFFAOYSA-N 509689 4-[[2-(5-Chloro-2-hydroxy-phenyl)acetyl]amino]-N-(1-ethynylcyclopentyl)pyridine-2-carboxamide::US11364246, Example 31.2::US20200361871A1, Example 31.2 Anoctamin-1 Homo sapiens 10.00 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509689 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509689&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347776 459280065 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067419 O[C@H]1CCCC[C@@H]1NC(=O)c1cc(NC(=O)Cc2cc(Cl)ccc2O)ccn1 InChI=1S/C20H22ClN3O4/c21-13-5-6-17(25)12(9-13)10-19(27)23-14-7-8-22-16(11-14)20(28)24-15-3-1-2-4-18(15)26/h5-9,11,15,18,25-26H,1-4,10H2,(H,24,28)(H,22,23,27)/t15-,18-/m0/s1 ZZUJLBRNDLRFAK-YJBOKZPZSA-N 509690 4-[2-(5-Chloro-2-hydroxyphenyl)acetamido]-N-[(1s,2s)-2-hydroxycyclohexyl] pyridine-2-carboxamide::US11364246, Example 31.3a::US20200361871A1, Example 31.3::US20200361871A1, Example 31.3a Anoctamin-1 Homo sapiens 210 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509690 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509690&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348182 459280066 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067420 O[C@H]1CCCC[C@@H]1NC(=O)c1cc(NC(=O)Cc2cc(Cl)ccc2O)ccn1 InChI=1S/C20H22ClN3O4/c21-13-5-6-17(25)12(9-13)10-19(27)23-14-7-8-22-16(11-14)20(28)24-15-3-1-2-4-18(15)26/h5-9,11,15,18,25-26H,1-4,10H2,(H,24,28)(H,22,23,27)/t15-,18-/m0/s1 ZZUJLBRNDLRFAK-YJBOKZPZSA-N 509690 4-[2-(5-Chloro-2-hydroxyphenyl)acetamido]-N-[(1s,2s)-2-hydroxycyclohexyl] pyridine-2-carboxamide::US11364246, Example 31.3a::US20200361871A1, Example 31.3::US20200361871A1, Example 31.3a Anoctamin-1 Homo sapiens 550 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509690 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509690&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348182 459280066 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067421 Oc1ccc(Cl)cc1CC(=O)Nc1ccnc(c1)C(=O)NC1(CCOCC1)C#C InChI=1S/C21H20ClN3O4/c1-2-21(6-9-29-10-7-21)25-20(28)17-13-16(5-8-23-17)24-19(27)12-14-11-15(22)3-4-18(14)26/h1,3-5,8,11,13,26H,6-7,9-10,12H2,(H,25,28)(H,23,24,27) IDGVUMSJNIRSMY-UHFFFAOYSA-N 509692 4-[[2-(5-Chloro-2-hydroxy-phenyl)acetyl]amino]-N-(4-ethynyltetrahydropyran-4-yl)pyridine-2-carboxamide::US11364246, Example 31.4::US20200361871A1, Example 31.4 Anoctamin-1 Homo sapiens 20.0 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509692 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509692&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348318 459280067 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067422 Oc1ccc(Cl)cc1CC(=O)Nc1ccnc(c1)C(=O)NCc1cccnc1 InChI=1S/C20H17ClN4O3/c21-15-3-4-18(26)14(8-15)9-19(27)25-16-5-7-23-17(10-16)20(28)24-12-13-2-1-6-22-11-13/h1-8,10-11,26H,9,12H2,(H,24,28)(H,23,25,27) JYROCEAOSNATMK-UHFFFAOYSA-N 509693 US11364246, Example 32.2::US20200361871A1, Example 32.2 Anoctamin-1 Homo sapiens 340 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509693 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509693&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347786 459280068 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067423 Oc1ccc(Cl)cc1CC(=O)Nc1ccnc(c1)C(=O)NCc1ccccn1 InChI=1S/C20H17ClN4O3/c21-14-4-5-18(26)13(9-14)10-19(27)25-15-6-8-23-17(11-15)20(28)24-12-16-3-1-2-7-22-16/h1-9,11,26H,10,12H2,(H,24,28)(H,23,25,27) CNNQSFJHKNJKGK-UHFFFAOYSA-N 509694 US11364246, Example 32.3::US20200361871A1, Example 32.3 Anoctamin-1 Homo sapiens 290 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509694 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509694&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348128 459280069 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067424 Oc1ccc(Cl)cc1CC(=O)Nc1ccnc(c1)C(=O)NCc1ccncc1 InChI=1S/C20H17ClN4O3/c21-15-1-2-18(26)14(9-15)10-19(27)25-16-5-8-23-17(11-16)20(28)24-12-13-3-6-22-7-4-13/h1-9,11,26H,10,12H2,(H,24,28)(H,23,25,27) ACLZUXNQQKHXBA-UHFFFAOYSA-N 509695 US11364246, Example 32.4::US20200361871A1, Example 32.4 Anoctamin-1 Homo sapiens 710 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509695 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509695&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348066 459280070 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067425 Oc1ccccc1CNC(=O)c1cc(NC(=O)Cc2cc(Cl)ccc2O)ccn1 InChI=1S/C21H18ClN3O4/c22-15-5-6-19(27)14(9-15)10-20(28)25-16-7-8-23-17(11-16)21(29)24-12-13-3-1-2-4-18(13)26/h1-9,11,26-27H,10,12H2,(H,24,29)(H,23,25,28) BZULUBBOQFXYIK-UHFFFAOYSA-N 509696 US11364246, Example 32.5::US20200361871A1, Example 32.5 Anoctamin-1 Homo sapiens 590 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509696 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509696&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347726 459280071 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067426 CC(C)(CN1CCOCC1)NC(=O)c1cc(NC(=O)Cc2cc(Cl)ccc2O)ccn1 InChI=1S/C22H27ClN4O4/c1-22(2,14-27-7-9-31-10-8-27)26-21(30)18-13-17(5-6-24-18)25-20(29)12-15-11-16(23)3-4-19(15)28/h3-6,11,13,28H,7-10,12,14H2,1-2H3,(H,26,30)(H,24,25,29) ADCCIRSCTJIHCH-UHFFFAOYSA-N 509697 US11364246, Example 32.6::US20200361871A1, Example 32.6 Anoctamin-1 Homo sapiens 820 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509697 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509697&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348100 459280072 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067427 CC(C)(CO)NC(=O)c1cc(NC(=O)Cc2cc(Cl)ccc2O)ccn1 InChI=1S/C18H20ClN3O4/c1-18(2,10-23)22-17(26)14-9-13(5-6-20-14)21-16(25)8-11-7-12(19)3-4-15(11)24/h3-7,9,23-24H,8,10H2,1-2H3,(H,22,26)(H,20,21,25) KEBCIUJLDXKIKI-UHFFFAOYSA-N 509698 US11364246, Example 32.7::US20200361871A1, Example 32.7 Anoctamin-1 Homo sapiens 200 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509698 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509698&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347751 459280073 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067428 O[C@@H]1CCC[C@H]1NC(=O)c1cc(NC(=O)Cc2cc(Cl)ccc2O)ccn1 InChI=1S/C19H20ClN3O4/c20-12-4-5-16(24)11(8-12)9-18(26)22-13-6-7-21-15(10-13)19(27)23-14-2-1-3-17(14)25/h4-8,10,14,17,24-25H,1-3,9H2,(H,23,27)(H,21,22,26)/t14-,17-/m1/s1 GAIOCIMFJMOPET-RHSMWYFYSA-N 509699 4-[[2-(5-Chloro-2-hydroxy-phenyl)acetyl]amino]-N-[(1R,2R)-2-hydroxycyclopentyl] pyridine-2-carboxamide::US11364246, Example 33::US20200361871A1, Example 33 Anoctamin-1 Homo sapiens 240 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509699 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509699&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347805 459280074 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067429 CC(C)(NC(=O)c1cc(NC(=O)Cc2cc(Cl)ccc2O)ccn1)C#N InChI=1S/C18H17ClN4O3/c1-18(2,10-20)23-17(26)14-9-13(5-6-21-14)22-16(25)8-11-7-12(19)3-4-15(11)24/h3-7,9,24H,8H2,1-2H3,(H,23,26)(H,21,22,25) XADDOWZCRQJSOT-UHFFFAOYSA-N 509700 4-[[2-(5-Chloro-2-hydroxy-phenyl)acetyl]amino]-N-(1-cyano-1-methyl-ethyl)pyridine-2-carboxamide::US11364246, Example 34::US20200361871A1, Example 34 Anoctamin-1 Homo sapiens 90.0 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509700 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509700&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348507 459280075 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067430 OCC1(CCOC1)NC(=O)c1cc(NC(=O)Cc2cc(Cl)ccc2O)ccn1 InChI=1S/C19H20ClN3O5/c20-13-1-2-16(25)12(7-13)8-17(26)22-14-3-5-21-15(9-14)18(27)23-19(10-24)4-6-28-11-19/h1-3,5,7,9,24-25H,4,6,8,10-11H2,(H,23,27)(H,21,22,26) IDTLKZCXRWOVMJ-UHFFFAOYSA-N 509701 4-[[2-(5-Chloro-2-hydroxy-phenyl)acetyl]amino]-N-[3-(hydroxymethyl) tetrahydrofuran-3-yl]pyridine-2-carboxamide::US11364246, Example 35::US20200361871A1, Example 35 Anoctamin-1 Homo sapiens 190 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509701 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509701&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348080 459280076 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067431 OC[C@@]1(CCOC1)NC(=O)c1cc(NC(=O)Cc2cc(Cl)ccc2O)ccn1 InChI=1S/C19H20ClN3O5/c20-13-1-2-16(25)12(7-13)8-17(26)22-14-3-5-21-15(9-14)18(27)23-19(10-24)4-6-28-11-19/h1-3,5,7,9,24-25H,4,6,8,10-11H2,(H,23,27)(H,21,22,26)/t19-/m1/s1 IDTLKZCXRWOVMJ-LJQANCHMSA-N 509702 US20200361871A1, Example 35a::US20200361871A1, Example 35b Anoctamin-1 Homo sapiens 100.0 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509702 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509702&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348070 459280077 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067432 OC[C@@]1(CCOC1)NC(=O)c1cc(NC(=O)Cc2cc(Cl)ccc2O)ccn1 InChI=1S/C19H20ClN3O5/c20-13-1-2-16(25)12(7-13)8-17(26)22-14-3-5-21-15(9-14)18(27)23-19(10-24)4-6-28-11-19/h1-3,5,7,9,24-25H,4,6,8,10-11H2,(H,23,27)(H,21,22,26)/t19-/m1/s1 IDTLKZCXRWOVMJ-LJQANCHMSA-N 509702 US20200361871A1, Example 35a::US20200361871A1, Example 35b Anoctamin-1 Homo sapiens 310 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509702 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509702&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348070 459280077 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067433 OC[C@@H]1CCCC[C@@H]1NC(=O)c1cc(NC(=O)Cc2cc(Cl)ccc2O)ccn1 InChI=1S/C21H24ClN3O4/c22-15-5-6-19(27)14(9-15)10-20(28)24-16-7-8-23-18(11-16)21(29)25-17-4-2-1-3-13(17)12-26/h5-9,11,13,17,26-27H,1-4,10,12H2,(H,25,29)(H,23,24,28)/t13-,17-/m0/s1 OXLGDFNYDQBYRM-GUYCJALGSA-N 509704 US11364246, Example 35.2::US20200361871A1, Example 35.2 Anoctamin-1 Homo sapiens 610 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509704 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509704&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347845 459280078 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067434 CC1(CC1)NC(=O)c1cc(NC(=O)Cc2cc(Cl)ccc2O)ccn1 InChI=1S/C18H18ClN3O3/c1-18(5-6-18)22-17(25)14-10-13(4-7-20-14)21-16(24)9-11-8-12(19)2-3-15(11)23/h2-4,7-8,10,23H,5-6,9H2,1H3,(H,22,25)(H,20,21,24) AGOBMKMEYFKNBY-UHFFFAOYSA-N 509705 US11364246, Example 35.8::US20200361871A1, Example 35.8 Anoctamin-1 Homo sapiens 180 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509705 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509705&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348329 459280079 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067435 CC(C)(NC(=O)c1cc(NC(=O)Cc2cc(Cl)ccc2O)ccn1)c1ccccn1 InChI=1S/C22H21ClN4O3/c1-22(2,19-5-3-4-9-25-19)27-21(30)17-13-16(8-10-24-17)26-20(29)12-14-11-15(23)6-7-18(14)28/h3-11,13,28H,12H2,1-2H3,(H,27,30)(H,24,26,29) VQWDYNGZBWZABS-UHFFFAOYSA-N 509706 US11364246, Example 35.9::US20200361871A1, Example 35.9 Anoctamin-1 Homo sapiens 540 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509706 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509706&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348519 459280080 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067436 Oc1ccc(Cl)cc1CC(=O)Nc1ccnc(c1)C(=O)NCCCc1ccccc1 InChI=1S/C23H22ClN3O3/c24-18-8-9-21(28)17(13-18)14-22(29)27-19-10-12-25-20(15-19)23(30)26-11-4-7-16-5-2-1-3-6-16/h1-3,5-6,8-10,12-13,15,28H,4,7,11,14H2,(H,26,30)(H,25,27,29) HZHCFAMMUNIQNC-UHFFFAOYSA-N 509707 US11364246, Example 35.10::US20200361871A1, Example 35.10 Anoctamin-1 Homo sapiens 280 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509707 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509707&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348408 459280081 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067437 COc1ccc(CNC(=O)c2cc(NC(=O)Cc3cc(Cl)ccc3O)ccn2)nc1 InChI=1S/C21H19ClN4O4/c1-30-17-4-3-16(24-12-17)11-25-21(29)18-10-15(6-7-23-18)26-20(28)9-13-8-14(22)2-5-19(13)27/h2-8,10,12,27H,9,11H2,1H3,(H,25,29)(H,23,26,28) IWBUVYKXCKVHAM-UHFFFAOYSA-N 509708 US11364246, Example 35.12::US20200361871A1, Example 35.12 Anoctamin-1 Homo sapiens 420 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509708 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509708&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347737 459280082 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067438 CCOC(=O)CC(C)(C)NC(=O)c1cc(NC(=O)Cc2cc(Cl)ccc2O)ccn1 InChI=1S/C21H24ClN3O5/c1-4-30-19(28)12-21(2,3)25-20(29)16-11-15(7-8-23-16)24-18(27)10-13-9-14(22)5-6-17(13)26/h5-9,11,26H,4,10,12H2,1-3H3,(H,25,29)(H,23,24,27) LKMWRLLCKDOHIG-UHFFFAOYSA-N 509709 US11364246, Example 35.13::US20200361871A1, Example 35.13 Anoctamin-1 Homo sapiens 350 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509709 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509709&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347963 459280083 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067439 CC(C)(CCO)NC(=O)c1cc(NC(=O)Cc2cc(Cl)ccc2O)ccn1 InChI=1S/C19H22ClN3O4/c1-19(2,6-8-24)23-18(27)15-11-14(5-7-21-15)22-17(26)10-12-9-13(20)3-4-16(12)25/h3-5,7,9,11,24-25H,6,8,10H2,1-2H3,(H,23,27)(H,21,22,26) SEGJWOFZUFHFBE-UHFFFAOYSA-N 509710 US11364246, Example 35.14::US20200361871A1, Example 35.14 Anoctamin-1 Homo sapiens 270 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509710 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509710&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348135 459280084 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067440 Oc1ccc(Cl)cc1CC(=O)Nc1ccnc(c1)C(=O)NCc1ccccc1 InChI=1S/C21H18ClN3O3/c22-16-6-7-19(26)15(10-16)11-20(27)25-17-8-9-23-18(12-17)21(28)24-13-14-4-2-1-3-5-14/h1-10,12,26H,11,13H2,(H,24,28)(H,23,25,27) GCJQRBLBGOUCHZ-UHFFFAOYSA-N 509711 US11364246, Example 35.15::US20200361871A1, Example 35.15 Anoctamin-1 Homo sapiens 150 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509711 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509711&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347733 459280085 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067441 Oc1ccc(Cl)cc1CC(=O)Nc1ccnc(c1)C(=O)Nc1ccccc1 InChI=1S/C20H16ClN3O3/c21-14-6-7-18(25)13(10-14)11-19(26)23-16-8-9-22-17(12-16)20(27)24-15-4-2-1-3-5-15/h1-10,12,25H,11H2,(H,24,27)(H,22,23,26) NDNVTNDOZMRNHE-UHFFFAOYSA-N 509712 US11364246, Example 35.16::US20200361871A1, Example 35.16 Anoctamin-1 Homo sapiens 330 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509712 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509712&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348267 459280086 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067442 O[C@H]1CCC[C@@H]1NC(=O)c1cc(NC(=O)Cc2cc(Cl)ccc2O)ccn1 InChI=1S/C19H20ClN3O4/c20-12-4-5-16(24)11(8-12)9-18(26)22-13-6-7-21-15(10-13)19(27)23-14-2-1-3-17(14)25/h4-8,10,14,17,24-25H,1-3,9H2,(H,23,27)(H,21,22,26)/t14-,17-/m0/s1 GAIOCIMFJMOPET-YOEHRIQHSA-N 509713 US11364246, Example 35.17::US20200361871A1, Example 35.17 Anoctamin-1 Homo sapiens 150 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509713 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509713&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348512 459280087 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067443 O[C@H]1CCC[C@H]1NC(=O)c1cc(NC(=O)Cc2cc(Cl)ccc2O)ccn1 InChI=1S/C19H20ClN3O4/c20-12-4-5-16(24)11(8-12)9-18(26)22-13-6-7-21-15(10-13)19(27)23-14-2-1-3-17(14)25/h4-8,10,14,17,24-25H,1-3,9H2,(H,23,27)(H,21,22,26)/t14-,17+/m1/s1 GAIOCIMFJMOPET-PBHICJAKSA-N 509714 US11364246, Example 35.18::US20200361871A1, Example 35.18 Anoctamin-1 Homo sapiens 430 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509714 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509714&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348349 459280088 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067444 O[C@@H]1CCC[C@@H]1NC(=O)c1cc(NC(=O)Cc2cc(Cl)ccc2O)ccn1 InChI=1S/C19H20ClN3O4/c20-12-4-5-16(24)11(8-12)9-18(26)22-13-6-7-21-15(10-13)19(27)23-14-2-1-3-17(14)25/h4-8,10,14,17,24-25H,1-3,9H2,(H,23,27)(H,21,22,26)/t14-,17+/m0/s1 GAIOCIMFJMOPET-WMLDXEAASA-N 509715 US11364246, Example 35.19::US20200361871A1, Example 35.19 Anoctamin-1 Homo sapiens 470 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509715 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509715&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347747 459280089 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067445 CC1(CCCCC1)NC(=O)c1cccc(NC(=O)Cc2cc(F)ccc2O)c1 InChI=1S/C22H25FN2O3/c1-22(10-3-2-4-11-22)25-21(28)15-6-5-7-18(13-15)24-20(27)14-16-12-17(23)8-9-19(16)26/h5-9,12-13,26H,2-4,10-11,14H2,1H3,(H,24,27)(H,25,28) VRVSJCDAWWCXBJ-UHFFFAOYSA-N 509716 US11364246, Example 35.20::US20200361871A1, Example 35.20 Anoctamin-1 Homo sapiens 420 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509716 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509716&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 152183931 459280090 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067446 CC(C)(NC(=O)c1cccc(NC(=O)Cc2cc(F)ccc2O)c1)C#C InChI=1S/C20H19FN2O3/c1-4-20(2,3)23-19(26)13-6-5-7-16(11-13)22-18(25)12-14-10-15(21)8-9-17(14)24/h1,5-11,24H,12H2,2-3H3,(H,22,25)(H,23,26) PFXPZDQRVDYKQQ-UHFFFAOYSA-N 509717 US11364246, Example 35.21::US20200361871A1, Example 35.21 Anoctamin-1 Homo sapiens 410 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509717 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509717&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348308 459280091 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067447 Oc1ccc(F)cc1CC(=O)Nc1cccc(c1)C(=O)NC1CCCCC1 InChI=1S/C21H23FN2O3/c22-16-9-10-19(25)15(11-16)13-20(26)23-18-8-4-5-14(12-18)21(27)24-17-6-2-1-3-7-17/h4-5,8-12,17,25H,1-3,6-7,13H2,(H,23,26)(H,24,27) YGCXZFLJPJKWNR-UHFFFAOYSA-N 509718 US11364246, Example 35.22::US20200361871A1, Example 35.22 Anoctamin-1 Homo sapiens 220 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509718 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509718&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347907 459280092 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067448 Oc1ccc(Cl)cc1CC(=O)Nc1ccnc(c1)C(=O)NC1(CCCCC1)C#C InChI=1S/C22H22ClN3O3/c1-2-22(9-4-3-5-10-22)26-21(29)18-14-17(8-11-24-18)25-20(28)13-15-12-16(23)6-7-19(15)27/h1,6-8,11-12,14,27H,3-5,9-10,13H2,(H,26,29)(H,24,25,28) XIYLOGFWZJKQRX-UHFFFAOYSA-N 509719 US11364246, Example 35.24::US20200361871A1, Example 35.24 Anoctamin-1 Homo sapiens 10.00 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509719 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509719&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348509 459280093 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067449 OCC1(CCC1)NC(=O)c1cc(NC(=O)Cc2cc(Cl)ccc2O)ccn1 InChI=1S/C19H20ClN3O4/c20-13-2-3-16(25)12(8-13)9-17(26)22-14-4-7-21-15(10-14)18(27)23-19(11-24)5-1-6-19/h2-4,7-8,10,24-25H,1,5-6,9,11H2,(H,23,27)(H,21,22,26) SVOIVVFZTMVTEX-UHFFFAOYSA-N 509720 US11364246, Example 35.25::US20200361871A1, Example 35.25 Anoctamin-1 Homo sapiens 100.0 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509720 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509720&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347799 459280094 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067450 COCC(C)(NC(=O)c1cc(NC(=O)Cc2cc(Cl)ccc2O)ccn1)C#N InChI=1S/C19H19ClN4O4/c1-19(10-21,11-28-2)24-18(27)15-9-14(5-6-22-15)23-17(26)8-12-7-13(20)3-4-16(12)25/h3-7,9,25H,8,11H2,1-2H3,(H,24,27)(H,22,23,26) IOWUSAGDRMEWML-UHFFFAOYSA-N 509721 US11364246, Example 35.27::US20200361871A1, Example 35.27 Anoctamin-1 Homo sapiens 330 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509721 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509721&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347773 459280095 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067451 CC(C)(NC(=O)c1cc(NC(=O)Cc2cc(Cl)ccc2O)ccn1)C#C InChI=1S/C19H18ClN3O3/c1-4-19(2,3)23-18(26)15-11-14(7-8-21-15)22-17(25)10-12-9-13(20)5-6-16(12)24/h1,5-9,11,24H,10H2,2-3H3,(H,23,26)(H,21,22,25) LSBYRABIJARLQT-UHFFFAOYSA-N 509722 4-[[2-(5-Chloro-2-hydroxy-phenyl)acetyl]amino]-N-(1,1-dimethylprop-2-ynyl)pyridine-2-carboxamide::US11364246, Example 36::US20200361871A1, Example 36 Anoctamin-1 Homo sapiens 20.0 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509722 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509722&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347764 459280096 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067452 CC(C)C(C)(NC(=O)c1cc(NC(=O)Cc2cc(Cl)ccc2O)ccn1)C#N InChI=1S/C20H21ClN4O3/c1-12(2)20(3,11-22)25-19(28)16-10-15(6-7-23-16)24-18(27)9-13-8-14(21)4-5-17(13)26/h4-8,10,12,26H,9H2,1-3H3,(H,25,28)(H,23,24,27) ONDXTUMYQWQGCA-UHFFFAOYSA-N 509723 4-[[2-(5-Chloro-2-hydroxy-phenyl)acetyl]amino]-N-(1-cyano-1,2-dimethyl-propyl)pyridine-2-carboxamide::US11364246, Example 37::US20200361871A1, Example 37 Anoctamin-1 Homo sapiens 120 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509723 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509723&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347863 459280097 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067453 CC1(CCCC1)NC(=O)c1cc(NC(=O)Cc2cc(Cl)ccc2O)ccn1 InChI=1S/C20H22ClN3O3/c1-20(7-2-3-8-20)24-19(27)16-12-15(6-9-22-16)23-18(26)11-13-10-14(21)4-5-17(13)25/h4-6,9-10,12,25H,2-3,7-8,11H2,1H3,(H,24,27)(H,22,23,26) VKZJOSLYEOHJBU-UHFFFAOYSA-N 509724 4-[[2-(5-Chloro-2-hydroxy-phenyl)acetyl]amino]-N-(1-methylcyclopentyl)pyridine-2-carboxamide::US11364246, Example 38::US20200361871A1, Example 38 Anoctamin-1 Homo sapiens 50.0 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509724 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509724&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348404 459280098 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067454 CC(C)(C)C1CCC(CC1)NC(=O)c1cc(NC(=O)Cc2cc(Cl)ccc2O)ccn1 InChI=1S/C24H30ClN3O3/c1-24(2,3)16-4-7-18(8-5-16)28-23(31)20-14-19(10-11-26-20)27-22(30)13-15-12-17(25)6-9-21(15)29/h6,9-12,14,16,18,29H,4-5,7-8,13H2,1-3H3,(H,28,31)(H,26,27,30) WRIAHBIPUXJQFH-UHFFFAOYSA-N 509725 N-(4-tert-Butylcyclohexyl)-4-[[2-(5-chloro-2-hydroxy-phenyl)acetyl]amino]pyridine-2-carboxamide (1:1 mixture cis/trans)::US11364246, Example 39::US20200361871A1, Example 39 Anoctamin-1 Homo sapiens 60.0 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509725 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509725&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348116 459280099 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067455 CC(C)(C)NC(=O)c1cc(NC(=O)Cc2cccc(F)c2Cl)ccn1 InChI=1S/C18H19ClFN3O2/c1-18(2,3)23-17(25)14-10-12(7-8-21-14)22-15(24)9-11-5-4-6-13(20)16(11)19/h4-8,10H,9H2,1-3H3,(H,23,25)(H,21,22,24) PUDCSXOPMFTVPO-UHFFFAOYSA-N 509726 N-tert-Butyl-4-[[2-(2-chloro-3-fluoro-phenyl)acetyl]amino] pyridine-2-carboxamide::US11364246, Example 40::US20200361871A1, Example 40 Anoctamin-1 Homo sapiens 700 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509726 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509726&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348351 459280100 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067456 CC(C)(C)NC(=O)c1cc(NC(=O)Cc2cc(F)ccc2Cl)ccn1 InChI=1S/C18H19ClFN3O2/c1-18(2,3)23-17(25)15-10-13(6-7-21-15)22-16(24)9-11-8-12(20)4-5-14(11)19/h4-8,10H,9H2,1-3H3,(H,23,25)(H,21,22,24) OQNLUTKHPYZRMF-UHFFFAOYSA-N 509727 N-tert-Butyl-4-[[2-(2-chloro-5-fluoro-phenyl)acetyl]amino] pyridine-2-carboxamide::US11364246, Example 40.1::US20200361871A1, Example 40.1 Anoctamin-1 Homo sapiens 870 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509727 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509727&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348160 459280101 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067457 OCCC1(CCOCC1)NC(=O)c1cc(NC(=O)Cc2cc(Cl)ccc2O)ccn1 InChI=1S/C21H24ClN3O5/c22-15-1-2-18(27)14(11-15)12-19(28)24-16-3-7-23-17(13-16)20(29)25-21(4-8-26)5-9-30-10-6-21/h1-3,7,11,13,26-27H,4-6,8-10,12H2,(H,25,29)(H,23,24,28) ZLYAVBSTFOWIBD-UHFFFAOYSA-N 509728 4-[[2-(5-Chloro-2-hydroxy-phenyl)acetyl]amino]-N-[4-(2-hydroxyethyl) tetrahydropyran-4-yl]pyridine-2-carboxamide::US11364246, Example 42::US20200361871A1, Example 42 Anoctamin-1 Homo sapiens 760 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509728 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509728&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348033 459280102 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067458 CC(C)(CCNCC(F)(F)F)NC(=O)c1cc(NC(=O)Cc2cc(Cl)ccc2O)ccn1 InChI=1S/C21H24ClF3N4O3/c1-20(2,6-8-26-12-21(23,24)25)29-19(32)16-11-15(5-7-27-16)28-18(31)10-13-9-14(22)3-4-17(13)30/h3-5,7,9,11,26,30H,6,8,10,12H2,1-2H3,(H,29,32)(H,27,28,31) PPKLGOWRIGPLEH-UHFFFAOYSA-N 509729 4-[[2-(5-Chloro-2-hydroxy-phenyl)acetyl]amino]-N-[1,1-dimethyl-3-(2,2,2-trifluoro ethylamino)propyl]pyridine-2-carboxamide::US11364246, Example 43::US20200361871A1, Example 43 Anoctamin-1 Homo sapiens 700 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509729 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509729&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348143 459280103 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067459 Oc1ccc(Cl)cc1CC(=O)Nc1ccnc(c1)C(=O)NC12CC(F)(C1)CC2 InChI=1S/C20H19ClFN3O3/c21-13-1-2-16(26)12(7-13)8-17(27)24-14-3-6-23-15(9-14)18(28)25-20-5-4-19(22,10-20)11-20/h1-3,6-7,9,26H,4-5,8,10-11H2,(H,25,28)(H,23,24,27) RLGMQPQSDBMCOS-UHFFFAOYSA-N 509730 4-[[2-(5-Chloro-2-hydroxy-phenyl)acetyl]amino]-N-(4-fluoro-1-bicyclo[2.1.1] hexanyl)pyridine-2-carboxamide::US11364246, Example 44::US20200361871A1, Example 44 Anoctamin-1 Homo sapiens 50.0 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509730 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509730&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347772 459280104 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067460 CC(CO)(NC(=O)c1cc(NC(=O)Cc2cc(Cl)ccc2O)ccn1)C#N InChI=1S/C18H17ClN4O4/c1-18(9-20,10-24)23-17(27)14-8-13(4-5-21-14)22-16(26)7-11-6-12(19)2-3-15(11)25/h2-6,8,24-25H,7,10H2,1H3,(H,23,27)(H,21,22,26) VSIHAKNETLOGDW-UHFFFAOYSA-N 509731 4-[[2-(5-Chloro-2-hydroxy-phenyl)acetyl]amino]-N-(1-cyano-2-hydroxy-1-methyl-ethyl)pyridine-2-carboxamide::US11364246, Example 46::US20200361871A1, Example 46 Anoctamin-1 Homo sapiens 250 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509731 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509731&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347744 459280105 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067461 C[C@](CO)(NC(=O)c1cc(NC(=O)Cc2cc(Cl)ccc2O)ccn1)C#N InChI=1S/C18H17ClN4O4/c1-18(9-20,10-24)23-17(27)14-8-13(4-5-21-14)22-16(26)7-11-6-12(19)2-3-15(11)25/h2-6,8,24-25H,7,10H2,1H3,(H,23,27)(H,21,22,26)/t18-/m0/s1 VSIHAKNETLOGDW-SFHVURJKSA-N 509732 US11364246, Example 46a::US20200361871A1, Example 46a Anoctamin-1 Homo sapiens 110 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509732 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509732&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348043 459280106 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067462 Oc1ccc(Cl)cc1CC(=O)Nc1ccnc(c1)C(=O)NC1(CCOC1)C#N InChI=1S/C19H17ClN4O4/c20-13-1-2-16(25)12(7-13)8-17(26)23-14-3-5-22-15(9-14)18(27)24-19(10-21)4-6-28-11-19/h1-3,5,7,9,25H,4,6,8,11H2,(H,24,27)(H,22,23,26) RMGQPEDSMAMMTF-UHFFFAOYSA-N 509733 4-[[2-(5-Chloro-2-hydroxy-phenyl)acetyl]amino]-N-(3-cyanotetrahydrofuran-3-yl)pyridine-2-carboxamide::US11364246, Example 47::US20200361871A1, Example 47 Anoctamin-1 Homo sapiens 180 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509733 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509733&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139366864 459280107 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067463 COC(=O)CC1(CCOCC1)NC(=O)c1cc(NC(=O)Cc2cc(Cl)ccc2O)ccn1 InChI=1S/C22H24ClN3O6/c1-31-20(29)13-22(5-8-32-9-6-22)26-21(30)17-12-16(4-7-24-17)25-19(28)11-14-10-15(23)2-3-18(14)27/h2-4,7,10,12,27H,5-6,8-9,11,13H2,1H3,(H,26,30)(H,24,25,28) IQVXDOGKLLWHFV-UHFFFAOYSA-N 509734 US11364246, Example 47.1::US20200361871A1, Example 47.1 Anoctamin-1 Homo sapiens 1920 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509734 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509734&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347920 459280108 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067464 COC(=O)C1(CCOCC1)NC(=O)c1cc(NC(=O)Cc2cc(Cl)ccc2O)ccn1 InChI=1S/C21H22ClN3O6/c1-30-20(29)21(5-8-31-9-6-21)25-19(28)16-12-15(4-7-23-16)24-18(27)11-13-10-14(22)2-3-17(13)26/h2-4,7,10,12,26H,5-6,8-9,11H2,1H3,(H,25,28)(H,23,24,27) KSIOMUUPFYDCEV-UHFFFAOYSA-N 509735 US11364246, Example 47.2::US20200361871A1, Example 47.2 Anoctamin-1 Homo sapiens 230 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509735 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509735&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347859 459280109 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067465 Oc1ccc(Cl)cc1CC(=O)Nc1ccnc(c1)C(=O)NC1(COC1)C#N InChI=1S/C18H15ClN4O4/c19-12-1-2-15(24)11(5-12)6-16(25)22-13-3-4-21-14(7-13)17(26)23-18(8-20)9-27-10-18/h1-5,7,24H,6,9-10H2,(H,23,26)(H,21,22,25) AAKJWGJLKRDGLD-UHFFFAOYSA-N 509736 US11364246, Example 47.3::US20200361871A1, Example 47.3 Anoctamin-1 Homo sapiens 350 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509736 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509736&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347828 459280110 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067466 CC1(CCC1)NC(=O)c1cc(NC(=O)Cc2cc(F)ccc2O)ccn1 InChI=1S/C19H20FN3O3/c1-19(6-2-7-19)23-18(26)15-11-14(5-8-21-15)22-17(25)10-12-9-13(20)3-4-16(12)24/h3-5,8-9,11,24H,2,6-7,10H2,1H3,(H,23,26)(H,21,22,25) HYYAEFICWUPXHP-UHFFFAOYSA-N 509737 4-[[2-(5-Fluoro-2-hydroxy-phenyl)acetyl]amino]-N-(1-methylcyclobutyl)pyridine-2-carboxamide::US11364246, Example 48::US20200361871A1, Example 48 Anoctamin-1 Homo sapiens 100.0 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509737 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509737&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347769 459280111 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067467 Oc1ccc(F)cc1CC(=O)Nc1ccnc(c1)C(=O)NC1(CCOCC1)C#N InChI=1S/C20H19FN4O4/c21-14-1-2-17(26)13(9-14)10-18(27)24-15-3-6-23-16(11-15)19(28)25-20(12-22)4-7-29-8-5-20/h1-3,6,9,11,26H,4-5,7-8,10H2,(H,25,28)(H,23,24,27) QMAGELZSZBHISS-UHFFFAOYSA-N 509738 N-(4-Cyanotetrahydropyran-4-yl)-4-[[2-(5-fluoro-2-hydroxy-phenyl)acetyl]amino] pyridine-2-carboxamide::US11364246, Example 48.1::US20200361871A1, Example 48.1 Anoctamin-1 Homo sapiens 420 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509738 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509738&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139366506 459280112 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067468 CC(C)(C)NC(=O)CC(C)(C)NC(=O)c1cc(NC(=O)Cc2cc(Cl)ccc2O)ccn1 InChI=1S/C23H29ClN4O4/c1-22(2,3)27-20(31)13-23(4,5)28-21(32)17-12-16(8-9-25-17)26-19(30)11-14-10-15(24)6-7-18(14)29/h6-10,12,29H,11,13H2,1-5H3,(H,27,31)(H,28,32)(H,25,26,30) ACFKYXABJBCQNV-UHFFFAOYSA-N 509739 N-[3-(tert-Butylamino)-1,1-dimethyl-3-oxo-propyl]-4-[[2-(5-chloro-2-hydroxy-phenyl) acetyl]amino]pyridine-2-carboxamide::US11364246, Example 49::US20200361871A1, Example 49 Anoctamin-1 Homo sapiens 680 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509739 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509739&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348410 459280113 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067469 OCC1(CCOCC1)NC(=O)c1cc(NC(=O)Cc2cc(Cl)ccc2O)ccn1 InChI=1S/C20H22ClN3O5/c21-14-1-2-17(26)13(9-14)10-18(27)23-15-3-6-22-16(11-15)19(28)24-20(12-25)4-7-29-8-5-20/h1-3,6,9,11,25-26H,4-5,7-8,10,12H2,(H,24,28)(H,22,23,27) KZXHNIUESJPLEP-UHFFFAOYSA-N 509740 4-[[2-(5-Chloro-2-hydroxy-phenyl)acetyl]amino]-N-[4-(hydroxymethyl)tetrahydro pyran-4-yl]pyridine-2-carboxamide::US11364246, Example 53::US20200361871A1, Example 53 Anoctamin-1 Homo sapiens 390 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509740 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509740&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347861 459280114 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067470 CC(C)(C)NC(=O)c1cc(NC(=O)[C@H]2CCc3c2c(O)ccc3Cl)ccn1 InChI=1S/C20H22ClN3O3/c1-20(2,3)24-19(27)15-10-11(8-9-22-15)23-18(26)13-5-4-12-14(21)6-7-16(25)17(12)13/h6-10,13,25H,4-5H2,1-3H3,(H,24,27)(H,22,23,26)/t13-/m0/s1 KUPRFSHCNZPXDT-ZDUSSCGKSA-N 509741 US11364246, Example 57b::US20200361871A1, Example 57a Anoctamin-1 Homo sapiens 510 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509741 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509741&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139366867 459280115 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067471 CC(C)(C)NC(=O)c1cc(NC(=O)[C@@H]2CCc3c2c(O)ccc3Cl)ccn1 InChI=1S/C20H22ClN3O3/c1-20(2,3)24-19(27)15-10-11(8-9-22-15)23-18(26)13-5-4-12-14(21)6-7-16(25)17(12)13/h6-10,13,25H,4-5H2,1-3H3,(H,24,27)(H,22,23,26)/t13-/m1/s1 KUPRFSHCNZPXDT-CYBMUJFWSA-N 509742 US11364246, Example 57a::US20200361871A1, Example 57b Anoctamin-1 Homo sapiens 670 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509742 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509742&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139366868 459280116 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067472 Fc1ccccc1CC(=O)Nc1ccnc(c1)C(=O)NC12CC(F)(C1)CC2 InChI=1S/C20H19F2N3O2/c21-15-4-2-1-3-13(15)9-17(26)24-14-5-8-23-16(10-14)18(27)25-20-7-6-19(22,11-20)12-20/h1-5,8,10H,6-7,9,11-12H2,(H,25,27)(H,23,24,26) FKEZXTUOUXKXSF-UHFFFAOYSA-N 509743 N-(4-Fluoro-1-bicyclo[2.1.1]hexanyl)-4-[[2-(2-fluorophenyl)acetyl]amino]pyridine-2-carboxamide::US11364246, Example 60::US20200361871A1, Example 60 Anoctamin-1 Homo sapiens 350 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509743 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509743&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139366518 459280117 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067473 CC(C)(NC(=O)c1cc(NC(=O)Cc2ccccc2F)ccn1)C#C InChI=1S/C19H18FN3O2/c1-4-19(2,3)23-18(25)16-12-14(9-10-21-16)22-17(24)11-13-7-5-6-8-15(13)20/h1,5-10,12H,11H2,2-3H3,(H,23,25)(H,21,22,24) RKYGREVGGNKECP-UHFFFAOYSA-N 509744 N-(1,1-Dimethylprop-2-ynyl)-4-[[2-(2-fluorophenyl)acetyl]amino]pyridine-2-carboxamide::US11364246, Example 60.2::US20200361871A1, Example 60.2 Anoctamin-1 Homo sapiens 200 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509744 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509744&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348216 459280118 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067474 CC(C)(C)NC(=O)c1cc(NC(=O)NCc2ccccc2Cl)ccn1 InChI=1S/C18H21ClN4O2/c1-18(2,3)23-16(24)15-10-13(8-9-20-15)22-17(25)21-11-12-6-4-5-7-14(12)19/h4-10H,11H2,1-3H3,(H,23,24)(H2,20,21,22,25) LZFGGFRUHGTFLQ-UHFFFAOYSA-N 509745 US11364246, Example 64.5::US20200361871A1, Example 64.5 Anoctamin-1 Homo sapiens 450 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509745 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509745&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348122 459280119 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067475 COc1ccccc1CNC(=O)Nc1ccnc(c1)C(=O)NC(C)(C)C InChI=1S/C19H24N4O3/c1-19(2,3)23-17(24)15-11-14(9-10-20-15)22-18(25)21-12-13-7-5-6-8-16(13)26-4/h5-11H,12H2,1-4H3,(H,23,24)(H2,20,21,22,25) LUMRFJAXQXDZQM-UHFFFAOYSA-N 509746 N-tert-Butyl-4-[(2-methoxyphenyl)methylcarbamoylamino]pyridine-2-carboxamide::US11364246, Example 65.1::US20200361871A1, Example 65.1 Anoctamin-1 Homo sapiens 470 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509746 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509746&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347762 459280120 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067476 CC(C)(C)NC(=O)c1cc(NC(=O)NCc2ccccc2O)ccn1 InChI=1S/C18H22N4O3/c1-18(2,3)22-16(24)14-10-13(8-9-19-14)21-17(25)20-11-12-6-4-5-7-15(12)23/h4-10,23H,11H2,1-3H3,(H,22,24)(H2,19,20,21,25) NXLRFAFBGMBNTR-UHFFFAOYSA-N 509747 N-tert-Butyl-4-[(2-hydroxyphenyl)methylcarbamoylamino]pyridine-2-carboxamide::US11364246, Example 65.2::US20200361871A1, Example 65.2 Anoctamin-1 Homo sapiens 480 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509747 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509747&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348220 459280121 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067477 CC(NCC(F)(F)F)c1ccc(O)c(CC(=O)Nc2ccnc(c2)C(=O)NC(C)(C)C)c1 InChI=1S/C22H27F3N4O3/c1-13(27-12-22(23,24)25)14-5-6-18(30)15(9-14)10-19(31)28-16-7-8-26-17(11-16)20(32)29-21(2,3)4/h5-9,11,13,27,30H,10,12H2,1-4H3,(H,29,32)(H,26,28,31) OLCKOUNZRMAOTI-UHFFFAOYSA-N 509748 N-tert-Butyl-4-[[2-[2-hydroxy-5-[1-(2,2,2-trifluoroethylamino)ethyl]phenyl] acetyl]amino]pyridine-2-carboxamide::US11364246, Example 67::US20200361871A1, Example 67 Anoctamin-1 Homo sapiens 1100 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509748 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509748&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347833 459280122 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067478 CC1(CCCCC1)NC(=O)c1cccc(NC(=O)Cc2cc(Cl)ccc2O)c1 InChI=1S/C22H25ClN2O3/c1-22(10-3-2-4-11-22)25-21(28)15-6-5-7-18(13-15)24-20(27)14-16-12-17(23)8-9-19(16)26/h5-9,12-13,26H,2-4,10-11,14H2,1H3,(H,24,27)(H,25,28) VFUUHSWJKONJIG-UHFFFAOYSA-N 509749 3-[[2-(5-Chloro-2-hydroxy-phenyl)acetyl]amino]-N-(1-methylcyclohexyl)benzamide::US11364246, Example 71.1::US20200361871A1, Example 71.1 Anoctamin-1 Homo sapiens 250 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509749 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509749&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348221 459280123 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067479 COCC(C)(CO)NC(=O)c1cc(NC(=O)Cc2cc(Cl)ccc2O)ccn1 InChI=1S/C19H22ClN3O5/c1-19(10-24,11-28-2)23-18(27)15-9-14(5-6-21-15)22-17(26)8-12-7-13(20)3-4-16(12)25/h3-7,9,24-25H,8,10-11H2,1-2H3,(H,23,27)(H,21,22,26) MCXWRVGPQNDJPC-UHFFFAOYSA-N 509750 4-[[2-(5-Chloro-2-hydroxy-phenyl)acetyl]amino]-N-[1-(hydroxymethyl)-2-methoxy-1-methyl-ethyl]pyridine-2-carboxamide::US11364246, Example 73::US20200361871A1, Example 73 Anoctamin-1 Homo sapiens 310 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509750 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509750&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348114 459280124 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067480 CC#CC(C)(C)NC(=O)c1cc(NC(=O)Cc2cc(Cl)ccc2O)ccn1 InChI=1S/C20H20ClN3O3/c1-4-8-20(2,3)24-19(27)16-12-15(7-9-22-16)23-18(26)11-13-10-14(21)5-6-17(13)25/h5-7,9-10,12,25H,11H2,1-3H3,(H,24,27)(H,22,23,26) ANAHWLJIKAXEBP-UHFFFAOYSA-N 509751 4-[[2-(5-Chloro-2-hydroxy-phenyl)acetyl]amino]-N-(1,1-dimethylbut-2-ynyl) pyridine-2-carboxamide::US11364246, Example 73.1::US20200361871A1, Example 73.1 Anoctamin-1 Homo sapiens 280 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509751 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509751&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348096 459280125 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067481 CC(C)(NC(=O)c1cccc(NC(=O)Cc2cc(Cl)ccc2O)c1)C#C InChI=1S/C20H19ClN2O3/c1-4-20(2,3)23-19(26)13-6-5-7-16(11-13)22-18(25)12-14-10-15(21)8-9-17(14)24/h1,5-11,24H,12H2,2-3H3,(H,22,25)(H,23,26) ODFQACNKFUMLRA-UHFFFAOYSA-N 509752 3-[[2-(5-Chloro-2-hydroxy-phenyl)acetyl]amino]-N-(1,1-dimethylprop-2-ynyl)benzamide::US11364246, Example 74::US20200361871A1, Example 74 Anoctamin-1 Homo sapiens 180 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509752 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509752&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347817 459280126 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067482 CC1(CCC1)NC(=O)c1cc(NC(=O)Cc2cc(Cl)c(F)cc2O)ccn1 InChI=1S/C19H19ClFN3O3/c1-19(4-2-5-19)24-18(27)15-9-12(3-6-22-15)23-17(26)8-11-7-13(20)14(21)10-16(11)25/h3,6-7,9-10,25H,2,4-5,8H2,1H3,(H,24,27)(H,22,23,26) BKSYNTRTEIEOBK-UHFFFAOYSA-N 509753 4-[[2-(5-Chloro-4-fluoro-2-hydroxy-phenyl)acetyl]amino]-N-(1-methylcyclo butyl)pyridine-2-carboxamide::US11364246, Example 76::US20200361871A1, Example 76 Anoctamin-1 Homo sapiens 220 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509753 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509753&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348036 459280127 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067483 CC(C)(OC(=O)c1cc(NC(=O)Cc2cc(F)ccc2F)ccn1)C#C InChI=1S/C19H16F2N2O3/c1-4-19(2,3)26-18(25)16-11-14(7-8-22-16)23-17(24)10-12-9-13(20)5-6-15(12)21/h1,5-9,11H,10H2,2-3H3,(H,22,23,24) SDTAXIVBRWGCPL-UHFFFAOYSA-N 509754 4-[[2-(2,5-Difluorophenyl)acetyl]amino]-N-(1,1-dimethylprop-2-ynyl)pyridine-2-carboxamide::US20200361871A1, Example 77 Anoctamin-1 Homo sapiens 410 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509754 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509754&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 155318100 459280128 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067484 Fc1ccc(F)c(CC(=O)Nc2ccnc(c2)C(=O)NC23CC(F)(C2)CC3)c1 InChI=1S/C20H18F3N3O2/c21-13-1-2-15(22)12(7-13)8-17(27)25-14-3-6-24-16(9-14)18(28)26-20-5-4-19(23,10-20)11-20/h1-3,6-7,9H,4-5,8,10-11H2,(H,26,28)(H,24,25,27) CNLOVXUOSKXAEX-UHFFFAOYSA-N 509755 4-[[2-(2,5-Difluorophenyl)acetyl]amino]-N-(4-fluoro-1-bicyclo[2.1.1]hexanyl) pyridine-2-carboxamide::US11364246, Example 77.1::US20200361871A1, Example 77.1 Anoctamin-1 Homo sapiens 540 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509755 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509755&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347842 459280129 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067485 CC(C)(NC(=O)c1cc(NC(=O)Cc2ccc(Cl)cc2O)ccn1)C#C InChI=1S/C19H18ClN3O3/c1-4-19(2,3)23-18(26)15-11-14(7-8-21-15)22-17(25)9-12-5-6-13(20)10-16(12)24/h1,5-8,10-11,24H,9H2,2-3H3,(H,23,26)(H,21,22,25) YLJPRJILFJVBHR-UHFFFAOYSA-N 509756 4-[[2-(4-Chloro-2-hydroxy-phenyl)acetyl]amino]-N-(1,1-dimethylprop-2-ynyl)pyridine-2-carboxamide::US11364246, Example 78::US20200361871A1, Example 78 Anoctamin-1 Homo sapiens 20.0 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509756 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509756&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347798 459280130 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067486 CC(C)(NC(=O)c1cc(NC(=O)Cc2ccc(cc2O)C(F)(F)F)ccn1)C#C InChI=1S/C20H18F3N3O3/c1-4-19(2,3)26-18(29)15-11-14(7-8-24-15)25-17(28)9-12-5-6-13(10-16(12)27)20(21,22)23/h1,5-8,10-11,27H,9H2,2-3H3,(H,26,29)(H,24,25,28) YVEJMOJKZHLTOY-UHFFFAOYSA-N 509757 N-(1,1-Dimethylprop-2-ynyl)-4-[[2-[2-hydroxy-4-(trifluoromethyl)phenyl]acetyl] amino]pyridine-2-carboxamide::US11364246, Example 78.1::US20200361871A1, Example 78.1 Anoctamin-1 Homo sapiens 50.0 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509757 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509757&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348232 459280131 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067487 CC(C)(NC(=O)c1cc(NC(=O)Cc2cc(ccc2O)C(F)(F)F)ccn1)C#C InChI=1S/C20H18F3N3O3/c1-4-19(2,3)26-18(29)15-11-14(7-8-24-15)25-17(28)10-12-9-13(20(21,22)23)5-6-16(12)27/h1,5-9,11,27H,10H2,2-3H3,(H,26,29)(H,24,25,28) HRPCFPRLKHWAGD-UHFFFAOYSA-N 509758 N-(1,1-Dimethylprop-2-ynyl)-4-[[2-[2-hydroxy-5-(trifluoromethyl)phenyl]acetyl] amino]pyridine-2-carboxamide::US11364246, Example 78.2::US20200361871A1, Example 78.2 Anoctamin-1 Homo sapiens 20.0 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509758 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509758&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348040 459280132 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067488 CC(C)(NC(=O)c1cc(NC(=O)Cc2cccc3cc[nH]c23)ccn1)C#C InChI=1S/C21H20N4O2/c1-4-21(2,3)25-20(27)17-13-16(9-11-22-17)24-18(26)12-15-7-5-6-14-8-10-23-19(14)15/h1,5-11,13,23H,12H2,2-3H3,(H,25,27)(H,22,24,26) FPZIMNCARQLCRO-UHFFFAOYSA-N 509759 N-(1,1-Dimethylprop-2-ynyl)-4-[[2-(1H-indol-7-yl)acetyl]amino]pyridine-2-carboxamide::US11364246, Example 79.3::US20200361871A1, Example 79.3 Anoctamin-1 Homo sapiens 240 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509759 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509759&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347758 459280133 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067489 CC(C)(NC(=O)c1cc(NC(=O)Cc2cc(F)ccc2O)ccn1)C#N InChI=1S/C18H17FN4O3/c1-18(2,10-20)23-17(26)14-9-13(5-6-21-14)22-16(25)8-11-7-12(19)3-4-15(11)24/h3-7,9,24H,8H2,1-2H3,(H,23,26)(H,21,22,25) UACWOJNUCIITHP-UHFFFAOYSA-N 509760 N-(1-Cyano-1-methyl-ethyl)-4-[[2-(5-fluoro-2-hydroxy-phenyl)acetyl]amino] pyridine-2-carboxamide::US11364246, Example 81::US20200361871A1, Example 81 Anoctamin-1 Homo sapiens 370 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509760 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509760&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348341 459280134 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067490 CC(C)NC(=O)c1cc(NC(=O)Cc2cc(F)ccc2O)ccn1 InChI=1S/C17H18FN3O3/c1-10(2)20-17(24)14-9-13(5-6-19-14)21-16(23)8-11-7-12(18)3-4-15(11)22/h3-7,9-10,22H,8H2,1-2H3,(H,20,24)(H,19,21,23) SBIUOSIRWHMIAD-UHFFFAOYSA-N 509761 4-[[2-(5-Fluoro-2-hydroxy-phenyl)acetyl]amino]-N-isopropyl-pyridine-2-carboxamide::US11364246, Example 81.2::US20200361871A1, Example 81.2 Anoctamin-1 Homo sapiens 420 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509761 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509761&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347709 459280135 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067491 CC(C)(NC(=O)c1cc(NC(=O)Cc2cc(F)ccc2O)ccn1)C#C InChI=1S/C19H18FN3O3/c1-4-19(2,3)23-18(26)15-11-14(7-8-21-15)22-17(25)10-12-9-13(20)5-6-16(12)24/h1,5-9,11,24H,10H2,2-3H3,(H,23,26)(H,21,22,25) KWTCHBSXZORGDL-UHFFFAOYSA-N 509762 N-(1,1-Dimethylprop-2-ynyl)-4-[[2-(5-fluoro-2-hydroxy-phenyl)acetyl]amino] pyridine-2-carboxamide::US11364246, Example 81.3::US20200361871A1, Example 81.3 Anoctamin-1 Homo sapiens 40.0 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509762 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509762&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347759 459280136 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067492 Oc1ccc(F)cc1CC(=O)Nc1ccnc(c1)C(=O)NC12CC(F)(C1)CC2 InChI=1S/C20H19F2N3O3/c21-13-1-2-16(26)12(7-13)8-17(27)24-14-3-6-23-15(9-14)18(28)25-20-5-4-19(22,10-20)11-20/h1-3,6-7,9,26H,4-5,8,10-11H2,(H,25,28)(H,23,24,27) VRALXWVEYHOHAK-UHFFFAOYSA-N 509763 N-(4-Fluoro-1-bicyclo[2.1.1]hexanyl)-4-[[2-(5-fluoro-2-hydroxy-phenyl)acetyl]amino] pyridine-2-carboxamide::US11364246, Example 81.4::US20200361871A1, Example 81.4 Anoctamin-1 Homo sapiens 40.0 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509763 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509763&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347719 459280137 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067493 COc1ccc(Cl)cc1CC(=O)Nc1cc(ncn1)C(=O)NC(C)(C)C InChI=1S/C18H21ClN4O3/c1-18(2,3)23-17(25)13-9-15(21-10-20-13)22-16(24)8-11-7-12(19)5-6-14(11)26-4/h5-7,9-10H,8H2,1-4H3,(H,23,25)(H,20,21,22,24) JVFWTSDJPDPKTO-UHFFFAOYSA-N 509764 N-tert-Butyl-6-[[2-(5-chloro-2-methoxy-phenyl)acetyl]amino]pyrimidine-4-carboxamide::US11364246, Example 82::US20200361871A1, Example 82 Anoctamin-1 Homo sapiens 720 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509764 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509764&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348106 459280138 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067494 CC(C)(C)NC(=O)c1cc(NC(=O)Cc2cc(Cl)ccc2O)ncn1 InChI=1S/C17H19ClN4O3/c1-17(2,3)22-16(25)12-8-14(20-9-19-12)21-15(24)7-10-6-11(18)4-5-13(10)23/h4-6,8-9,23H,7H2,1-3H3,(H,22,25)(H,19,20,21,24) IVBZPWMDHKHHTR-UHFFFAOYSA-N 509765 N-tert-Butyl-6-[[2-(5-chloro-2-hydroxy-phenyl)acetyl]amino] pyrimidine-4-carboxamide::US11364246, Example 85::US20200361871A1, Example 85 Anoctamin-1 Homo sapiens 350 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509765 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509765&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348194 459280139 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067495 COCC(COC)(NC(=O)c1cc(NC(=O)Cc2cc(Cl)ccc2O)ccn1)C#N InChI=1S/C20H21ClN4O5/c1-29-11-20(10-22,12-30-2)25-19(28)16-9-15(5-6-23-16)24-18(27)8-13-7-14(21)3-4-17(13)26/h3-7,9,26H,8,11-12H2,1-2H3,(H,25,28)(H,23,24,27) JNFNBXYOVJNWMV-UHFFFAOYSA-N 509766 4-[[2-(5-Chloro-2-hydroxy-phenyl)acetyl]amino]-N-[1-cyano-2-methoxy-1-(methoxy methyl)ethyl]pyridine-2-carboxamide::US11364246, Example 86::US20200361871A1, Example 86 Anoctamin-1 Homo sapiens 350 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509766 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509766&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348020 459280140 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067496 CC(C)(C)NC(=O)c1cc(NC(=O)Cc2ccc(c(N)c2)C(C)(C)C)ccn1 InChI=1S/C22H30N4O2/c1-21(2,3)16-8-7-14(11-17(16)23)12-19(27)25-15-9-10-24-18(13-15)20(28)26-22(4,5)6/h7-11,13H,12,23H2,1-6H3,(H,26,28)(H,24,25,27) ZJAGBRRCQVZDSL-UHFFFAOYSA-N 509767 US11364246, Example 87::US20200361871A1, Example 87 Anoctamin-1 Homo sapiens 220 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509767 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509767&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347945 459280141 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067497 CC(C)(C)NC(=O)c1cc(NC(=O)Cc2ccc(cc2N)C(C)(C)C)ccn1 InChI=1S/C22H30N4O2/c1-21(2,3)15-8-7-14(17(23)12-15)11-19(27)25-16-9-10-24-18(13-16)20(28)26-22(4,5)6/h7-10,12-13H,11,23H2,1-6H3,(H,26,28)(H,24,25,27) VMFGYVSINRYPTH-UHFFFAOYSA-N 509768 US11364246, Example 88::US20200361871A1, Example 88 Anoctamin-1 Homo sapiens 240 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509768 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509768&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347740 459280142 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067498 CC(C)(C)NC(=O)c1cc(NC(=O)Cc2ccc(c(O)c2)C(C)(C)C)ccn1 InChI=1S/C22H29N3O3/c1-21(2,3)16-8-7-14(11-18(16)26)12-19(27)24-15-9-10-23-17(13-15)20(28)25-22(4,5)6/h7-11,13,26H,12H2,1-6H3,(H,25,28)(H,23,24,27) RXOORUPPIHCNQN-UHFFFAOYSA-N 509769 N-tert-Butyl-4-[[2-(4-tert-butyl-3-hydroxy-phenyl)acetyl]amino]pyridine-2-carboxamide::US11364246, Example 89::US20200361871A1, Example 89 Anoctamin-1 Homo sapiens 90.0 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509769 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509769&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348111 459280143 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067499 CC(C)(C)NC(=O)c1cc(NC(=O)Cc2ccc(cc2O)C(C)(C)C)ccn1 InChI=1S/C22H29N3O3/c1-21(2,3)15-8-7-14(18(26)12-15)11-19(27)24-16-9-10-23-17(13-16)20(28)25-22(4,5)6/h7-10,12-13,26H,11H2,1-6H3,(H,25,28)(H,23,24,27) CGIWNSVYWLSLAG-UHFFFAOYSA-N 509770 N-tert-Butyl-4-[[2-(4-tert-butyl-2-hydroxy-phenyl)acetyl]amino]pyridine-2-carboxamide::US11364246, Example 90::US20200361871A1, Example 90 Anoctamin-1 Homo sapiens 120 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509770 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509770&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348016 459280144 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067500 Oc1cc(CC(=O)Nc2ccnc(c2)C(=O)NC2(CCOCC2)C#N)ccc1Cl InChI=1S/C20H19ClN4O4/c21-15-2-1-13(9-17(15)26)10-18(27)24-14-3-6-23-16(11-14)19(28)25-20(12-22)4-7-29-8-5-20/h1-3,6,9,11,26H,4-5,7-8,10H2,(H,25,28)(H,23,24,27) OCQIWHDKKINGOA-UHFFFAOYSA-N 509771 4-[[2-(4-Chloro-3-hydroxy-phenyl)acetyl]amino]-N-(4-cyanotetrahydropyran-4-yl)pyridine-2-carboxamide::US11364246, Example 92::US20200361871A1, Example 92 Anoctamin-1 Homo sapiens 110 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509771 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509771&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348084 459280145 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067501 CC(C)(NC(=O)c1cc(NC(=O)Cc2ccc(Cl)c(O)c2)ccn1)C#N InChI=1S/C18H17ClN4O3/c1-18(2,10-20)23-17(26)14-9-12(5-6-21-14)22-16(25)8-11-3-4-13(19)15(24)7-11/h3-7,9,24H,8H2,1-2H3,(H,23,26)(H,21,22,25) SIPFQZLECWRUCV-UHFFFAOYSA-N 509772 US11364246, Example 92.2::US20200361871A1, Example 92.1 Anoctamin-1 Homo sapiens 140 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509772 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509772&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347851 459280146 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067502 CC(C)(NC(=O)c1cc(NC(=O)Cc2ccc(Cl)c(O)c2)ccn1)C#C InChI=1S/C19H18ClN3O3/c1-4-19(2,3)23-18(26)15-11-13(7-8-21-15)22-17(25)10-12-5-6-14(20)16(24)9-12/h1,5-9,11,24H,10H2,2-3H3,(H,23,26)(H,21,22,25) KTRJIUHBRNTCIR-UHFFFAOYSA-N 509773 US20200361871A1, Example 92.2 Anoctamin-1 Homo sapiens 10.00 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509773 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509773&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347929 459280147 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067503 CC(C)(C)c1ccc(CC(=O)Nc2ccnc(c2)C(=O)NC2CCCC[C@@H]2O)cc1O InChI=1S/C24H31N3O4/c1-24(2,3)17-9-8-15(12-21(17)29)13-22(30)26-16-10-11-25-19(14-16)23(31)27-18-6-4-5-7-20(18)28/h8-12,14,18,20,28-29H,4-7,13H2,1-3H3,(H,27,31)(H,25,26,30)/t18?,20-/m0/s1 FDPYPICKNADJGC-IJHRGXPZSA-N 509774 US11364246, Example 93.1::US20200361871A1, Example 93.1 Anoctamin-1 Homo sapiens 50.0 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509774 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509774&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348419 459280148 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067504 CC(C)(C)c1ccc(CC(=O)Nc2ccnc(c2)C(=O)NC2CCC[C@@H]2O)cc1O InChI=1S/C23H29N3O4/c1-23(2,3)16-8-7-14(11-20(16)28)12-21(29)25-15-9-10-24-18(13-15)22(30)26-17-5-4-6-19(17)27/h7-11,13,17,19,27-28H,4-6,12H2,1-3H3,(H,26,30)(H,24,25,29)/t17?,19-/m0/s1 DHKGMRBDBKUTEK-NNBQYGFHSA-N 509775 US11364246, Example 93.2::US20200361871A1, Example 93.2 Anoctamin-1 Homo sapiens 40.0 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509775 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509775&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348164 459280149 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067505 CC(C)(C)c1ccc(CC(=O)Nc2ccnc(c2)C(=O)NC2(CCOCC2)C#N)cc1O InChI=1S/C24H28N4O4/c1-23(2,3)18-5-4-16(12-20(18)29)13-21(30)27-17-6-9-26-19(14-17)22(31)28-24(15-25)7-10-32-11-8-24/h4-6,9,12,14,29H,7-8,10-11,13H2,1-3H3,(H,28,31)(H,26,27,30) PWRDZRPWDPAOLV-UHFFFAOYSA-N 509776 US11364246, Example 93.3::US20200361871A1, Example 93.3 Anoctamin-1 Homo sapiens 60.0 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509776 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509776&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348331 459280150 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067506 CC(C)(C)c1ccc(CC(=O)Nc2ccnc(c2)C(=O)NC(C)(C)C#N)cc1O InChI=1S/C22H26N4O3/c1-21(2,3)16-7-6-14(10-18(16)27)11-19(28)25-15-8-9-24-17(12-15)20(29)26-22(4,5)13-23/h6-10,12,27H,11H2,1-5H3,(H,26,29)(H,24,25,28) JEDRHERDCRDSGR-UHFFFAOYSA-N 509777 US11364246, Example 93.4::US20200361871A1, Example 93.4 Anoctamin-1 Homo sapiens 70.0 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509777 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509777&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348031 459280151 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067507 CC(C)(C)c1ccc(CC(=O)Nc2ccnc(c2)C(=O)NC(C)(C)C#C)cc1O InChI=1S/C23H27N3O3/c1-7-23(5,6)26-21(29)18-14-16(10-11-24-18)25-20(28)13-15-8-9-17(19(27)12-15)22(2,3)4/h1,8-12,14,27H,13H2,2-6H3,(H,26,29)(H,24,25,28) BGOJNEKEZDRTEW-UHFFFAOYSA-N 509778 US11364246, Example 93.5::US20200361871A1, Example 93.5 Anoctamin-1 Homo sapiens 20.0 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509778 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509778&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139348093 459280152 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3 1067508 CC(C)(NC(=O)c1cc(NC(=O)Cc2cc(Cl)ccc2O)ccn1)c1ccccc1 InChI=1S/C23H22ClN3O3/c1-23(2,16-6-4-3-5-7-16)27-22(30)19-14-18(10-11-25-19)26-21(29)13-15-12-17(24)8-9-20(15)28/h3-12,14,28H,13H2,1-2H3,(H,27,30)(H,25,26,29) ZBSZBVUTNFFIKX-UHFFFAOYSA-N 509779 4-[[2-(5-Chloro-2-hydroxy-phenyl)acetyl]amino]-N-(1-methyl-1-phenyl-ethyl) pyridine-2-carboxamide::US11364246, Example 94::US20200361871A1, Example 94 Anoctamin-1 Homo sapiens 340 US Patent 10.7270/Q2M32ZXP aid1805741 US20200361871 Collingwood, S; Mccarthy, C; Hargrave, JD; Hay, DA; Schofield, TB; Ellam, S; Buxton, C; Habgood, M; Ingram, P; Ma, CY; Napier, S; Shaikh, A; Smith, M; Stimson, C; Walker, E 11/19/2020 1/13/2022 Enterprise Therapeutics Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=509779 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006087&target=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=509779&enzyme=Anoctamin-1&column=ki&startPg=0&Increment=50&submit=Search 139347839 459280153 1 MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLVRRVQHSDTPSGARSVKQDHPLPGKGASLDAGSGEPPMDYHEDDKRFRREEYEGNLLEAGLELERDEDTKIHGVGFVKIHAPWNVLCREAEFLKLKMPTKKMYHINETRGLLKKINSVLQKITDPIQPKVAEHRPQTMKRLSYPFSREKQHLFDLSDKDSFFDSKTRSTIVYEILKRTTCTKAKYSMGITSLLANGVYAAAYPLHDGDYNGENVEFNDRKLLYEEWARYGVFYKYQPIDLVRKYFGEKIGLYFAWLGVYTQMLIPASIVGIIVFLYGCATMDENIPSMEMCDQRHNITMCPLCDKTCSYWKMSSACATARASHLFDNPATVFFSVFMALWAATFMEHWKRKQMRLNYRWDLTGFEEEEEAVKDHPRAEYEARVLEKSLKKESRNKEKRRHIPEESTNKWKQRVKTAMAGVKLTDKVKLTWRDRFPAYLTNLVSIIFMIAVTFAIVLGVIIYRISMAAALAMNSSPSVRSNIRVTVTATAVIINLVVIILLDEVYGCIARWLTKIEVPKTEKSFEERLIFKAFLLKFVNSYTPIFYVAFFKGRFVGRPGDYVYIFRSFRMEECAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIRYLKLKQQSPPDHEECVKRKQRYEVDYNLEPFAGLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRPVAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNGTMHGFVNHTLSSFNVSDFQNGTAPNDPLDLGYEVQICRYKDYREPPWSENKYDISKDFWAVLAARLAFVIVFQNLVMFMSDFVDWVIPDIPKDISQQIHKEKVLMVELFMREEQDKQQLLETWMEKERQKDEPPCNHHNTKACPDSLGSPAPSHAYHGGVL 6BGI,6BGJ Anoctamin-1 ANO1_HUMAN Q5XXA6 A0A2H4Y9B2 A8KAM3 E9PNA7 Q8IYY8 Q8N7V3